"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type"
"CHEMBL3960048";"";"None";"381.46";"0";"2.62";"BDBM205214";"CN(C)Cc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"1250.0";"nM";"5.90";"";"363281";"UO_0000065";"15.47";"0.30";"3.28";"5.83";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3890128";"";"None";"411.49";"0";"1.75";"BDBM205218";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1cnn(CC2CCNCC2)c1";"IC50";"'='";"7900.0";"nM";"5.10";"";"363285";"UO_0000065";"12.40";"0.24";"3.35";"3.99";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2207206";"";"None";"433.56";"0";"4.01";"19c";"Cc1nn(C)c2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)ccc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.81";"0.35";"4.14";"8.43";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207178";"";"None";"446.28";"0";"3.14";"10e";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)c1cnccn1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"17.16";"0.37";"4.52";"7.31";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3125731";"";"None";"408.48";"0";"3.74";"15";"COCCNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"16.57";"0.32";"3.03";"7.60";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3650747";"";"None";"471.57";"0";"2.58";"BDBM148131";"CN(C)CCNc1ccc(Nc2nccc(-c3ccc(N4CCC[C@@H]4C(N)=O)c(C#N)c3)n2)cn1";"IC50";"'<'";"300.0";"nM";"";"";"286112";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2207184";"";"None";"371.46";"0";"3.64";"11";"CCc1cnc(Nc2cccc(F)c2)nc1NCCCNC(=O)C1CCC1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"19.38";"0.36";"3.56";"9.12";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3650735";"";"None";"456.55";"0";"2.48";"BDBM148119";"CN1CCN(c2ccc(Nc3nccc(-c4ccc(N5CC[C@H](O)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286100";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2011898";"";"None";"487.45";"0";"4.23";"1d";"CN(C)CCNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12";"IC50";"'='";"10300.0";"nM";"4.99";"";"";"UO_0000065";"10.23";"0.22";"0.76";"7.20";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011914";"";"None";"372.27";"0";"4.03";"2l";"CNc1c(Br)cnc2[nH]c(-c3ccc(N4CCCC4)cc3)nc12";"IC50";"'='";"388.0";"nM";"6.41";"";"";"UO_0000065";"17.22";"0.38";"2.38";"11.28";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4436416";"";"None";"498.51";"0";"3.70";"21";"Cn1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)cn1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"14.56";"0.28";"3.56";"7.64";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4295050";"";"None";"326.35";"0";"3.21";"117";"CC(C)CCc1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"10715193.05";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4279336";"";"None";"338.32";"0";"2.43";"148";"Nc1nc2oc3ccc(C4=CCOCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"257039.58";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3979474";"";"None";"521.53";"1";"2.51";"BDBM245994";"N#Cc1cc(-c2nc(Nc3ccnc(NC(=O)CN4CCOCC4)c3)ncc2F)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429077";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3984119";"";"None";"474.54";"0";"3.32";"BDBM246000";"CO[C@H]1CCN(Cc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)C1";"IC50";"'<'";"30.0";"nM";"";"";"429083";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109238";"";"None";"390.41";"0";"1.94";"BDBM246035";"Cn1cc(Nc2nccc(-c3cnc(N4CCC[C@@H]4C(=O)O)c(C#N)c3)n2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"429118";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895278";"";"None";"492.53";"0";"3.52";"BDBM246081";"N#Cc1nc(-c2ccnc(Nc3ccc(OCCN4CC[C@H](F)C4)nc3)n2)ccc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429164";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959400";"";"None";"517.57";"1";"2.49";"BDBM245957";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CN4CCC(O)CC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429040";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915872";"";"None";"459.53";"0";"3.53";"BDBM245958";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)cc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429041";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975437";"";"None";"487.54";"0";"3.13";"BDBM245969";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CN4CCCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429052";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980158";"";"None";"415.48";"0";"3.65";"BDBM245979";"CN1Cc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cc2C1";"IC50";"'<'";"15.0";"nM";"";"";"429062";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3896079";"";"None";"533.57";"2";"2.19";"BDBM245989";"N#Cc1cc(-c2nc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)ncc2F)cnc1N1CCCOCC1";"IC50";"'<'";"100.0";"nM";"";"";"429072";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3978449";"";"None";"478.51";"0";"3.07";"BDBM245992";"N#Cc1cc(-c2nc(Nc3ccc(CN4CCOCC4)nc3)ncc2F)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429075";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3931468";"";"None";"472.55";"0";"2.61";"BDBM246070";"CN(c1ncc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cc1C#N)C1CCOC1";"IC50";"'<'";"100.0";"nM";"";"";"429153";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3917806";"";"None";"490.54";"0";"2.54";"BDBM246082";"N#Cc1nc(-c2ccnc(Nc3ccc(OCCN4CC[C@H](F)C4)nc3)n2)ccc1N1CC[C@H](O)C1";"IC50";"'<'";"100.0";"nM";"";"";"429165";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125736";"";"None";"374.40";"0";"4.04";"5";"CNc1c(-c2ccc(C(=O)O)cc2)cnc2[nH]c(-c3ccc(OC)cc3)nc12";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"15.34";"0.28";"1.70";"5.74";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4284757";"";"None";"362.39";"0";"3.15";"168";"Nc1nc2oc3ccc(C4CCCCC4)cc3c(=O)c2cc1-c1nn[nH]n1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"15.79";"0.29";"2.57";"4.63";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4281039";"";"None";"296.28";"0";"2.65";"107";"C=C(C)c1ccc2c(=O)c3cc(C(=O)O)c(N)nc3oc2c1";"IC50";"'='";"2290.87";"nM";"5.64";"";"";"UO_0000065";"19.04";"0.35";"2.99";"5.30";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL2207190";"";"None";"425.53";"0";"4.40";"15c";"O=C(NCCCNc1nc(NCc2ccc(F)cc2)ncc1C1CC1)c1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4277614";"";"None";"296.28";"0";"2.65";"105";"C=C(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"19.87";"0.37";"3.24";"5.53";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4281039";"";"None";"296.28";"0";"2.65";"107";"C=C(C)c1ccc2c(=O)c3cc(C(=O)O)c(N)nc3oc2c1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"19.03";"0.35";"2.99";"5.30";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4288939";"";"None";"298.30";"0";"2.75";"108";"CC(C)c1cccc2oc3nc(N)c(C(=O)O)cc3c(=O)c12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"19.98";"0.37";"3.21";"5.60";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4284443";"";"None";"316.29";"0";"2.88";"109";"CC(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cc1F";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"20.23";"0.38";"3.52";"6.01";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4292344";"";"None";"314.27";"0";"2.79";"110";"C=C(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cc1F";"IC50";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"19.42";"0.36";"3.31";"5.73";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3125722";"";"None";"520.62";"1";"4.56";"24";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)O)cs4)cnc3[nH]2)cc1";"IC50";"'='";"2170.0";"nM";"5.66";"";"";"UO_0000065";"10.88";"0.21";"1.10";"3.99";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125728";"";"None";"420.54";"1";"5.14";"18";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"16.90";"0.32";"1.97";"8.90";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125726";"";"None";"420.54";"1";"5.14";"20";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"17.89";"0.34";"2.38";"9.42";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125734";"";"None";"349.42";"0";"4.56";"12";"COc1ccc(-c2nc3cc(-c4csc(C(C)=O)c4)cnc3[nH]2)cc1";"IC50";"'='";"1780.0";"nM";"5.75";"";"";"UO_0000065";"16.45";"0.31";"1.19";"8.47";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL2011936";"";"None";"472.39";"0";"4.50";"4";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.14";"0.37";"3.60";"8.81";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3687169";"";"None";"445.52";"0";"4.15";"BDBM144203";"N#Cc1cc(-c2ccnc(Nc3cnn(CC4CCOC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"85.0";"nM";"7.07";"";"280355";"UO_0000065";"15.87";"0.29";"2.92";"7.50";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682420";"";"None";"445.53";"0";"3.44";"BDBM144127";"N#Cc1cc(-c2ccnc(Nc3cnn(C4CCNCC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"280373";"UO_0000065";"18.45";"0.34";"4.78";"7.48";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682426";"";"None";"403.44";"0";"3.20";"BDBM144133";"N#Cc1cc(-c2ccnc(Nc3cc(CO)ccn3)n2)ccc1OC1CCOCC1";"IC50";"'='";"180.0";"nM";"6.75";"";"280379";"UO_0000065";"16.72";"0.31";"3.54";"5.96";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682429";"";"None";"460.54";"0";"3.99";"BDBM144136";"N#Cc1cc(-c2ccnc(Nc3cnn([C@H]4CC[C@@H](O)CC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"280382";"UO_0000065";"17.58";"0.33";"4.11";"6.86";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687111";"";"None";"429.52";"0";"4.38";"BDBM144144";"CN(C)Cc1ccnc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ccn2)c1";"IC50";"'='";"14.0";"nM";"7.85";"";"280390";"UO_0000065";"18.29";"0.34";"3.47";"9.43";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687123";"";"None";"377.40";"0";"3.61";"BDBM144156";"Cc1coc(Nc2nccc(-c3ccc(OC4CCOCC4)c(C#N)c3)n2)n1";"IC50";"'='";"550.0";"nM";"6.26";"";"280402";"UO_0000065";"16.59";"0.31";"2.65";"5.90";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687132";"";"None";"404.47";"0";"3.78";"BDBM144166";"COCCn1cc(Nc2nccc(-c3ccc(OCC4CCC4)c(C#N)c3)n2)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"280412";"UO_0000065";"20.16";"0.37";"4.37";"8.33";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687140";"";"None";"403.49";"0";"4.39";"BDBM144174";"COCCn1cc(Nc2cc(-c3ccc(OCC4CCC4)c(C#N)c3)ccn2)cn1";"IC50";"'='";"490.0";"nM";"6.31";"";"280419";"UO_0000065";"15.64";"0.29";"1.92";"7.42";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3218297";"";"None";"422.49";"0";"3.23";"5g-Mes";"CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3224498";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217586";"1";"Scientific Literature";"Medchemcomm";"2012";"None";"";""
"CHEMBL3949617";"";"None";"455.50";"0";"3.65";"BDBM245984";"Cc1nccn1Cc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429067";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975272";"";"None";"503.54";"1";"2.37";"BDBM246076";"N#Cc1nc(-c2ccnc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)n2)ccc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429159";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4549459";"";"None";"500.49";"1";"3.66";"3";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"2270.0";"nM";"5.64";"";"";"UO_0000065";"11.28";"0.21";"1.98";"4.86";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3650707";"";"None";"388.44";"0";"2.04";"BDBM148091";"N#Cc1cc(-c2ccnc(Nc3ccn(CC(N)=O)n3)n2)ccc1N1CCCC1";"IC50";"'<'";"300.0";"nM";"";"";"286078";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3946780";"";"None";"460.52";"0";"2.93";"BDBM246003";"N#Cc1cc(-c2ccnc(Nc3cncc(CN4CCOCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429086";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3922477";"";"None";"484.56";"0";"2.84";"BDBM246021";"N#Cc1cc(-c2ccnc(Nc3cccc(C(=O)NC4CCNCC4)c3)n2)cnc1NC1CCOC1";"IC50";"'<'";"1000.0";"nM";"";"";"429104";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3985702";"";"None";"445.53";"0";"2.46";"BDBM246024";"CN1CCC(Nc2ccc(Nc3nccc(-c4cnc(NCCO)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"429107";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943196";"";"None";"406.45";"0";"1.30";"BDBM246033";"N#Cc1cc(-c2ccnc(Nc3cnn(C[C@H](O)CO)c3)n2)cnc1N1CCCC1";"IC50";"'<'";"15.0";"nM";"";"";"429116";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3903934";"";"None";"508.53";"1";"3.20";"BDBM246060";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CCC(OC(F)F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429143";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941055";"";"None";"485.55";"0";"1.71";"BDBM246062";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CCNC(=O)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"429145";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3939994";"";"None";"460.54";"0";"2.46";"BDBM246069";"COCCN(C)c1ncc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cc1C#N";"IC50";"'<'";"1000.0";"nM";"";"";"429152";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918912";"";"None";"362.40";"0";"1.46";"BDBM246073";"Cn1cc(Nc2nccc(-c3ccc(N4CC[C@H](O)C4)c(C#N)n3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429156";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125722";"";"None";"520.62";"1";"4.56";"24";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)O)cs4)cnc3[nH]2)cc1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"14.30";"0.27";"2.88";"5.24";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125729";"";"None";"420.54";"1";"5.14";"17";"CCC(C)CNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"16.77";"0.32";"1.91";"8.82";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3910408";"";"None";"544.64";"1";"3.06";"BDBM245951";"CC(C)N1CCN(CC(=O)Nc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"429034";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3934205";"";"None";"474.54";"0";"3.32";"BDBM245981";"C[C@H]1COCCN1Cc1cc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)ccn1";"IC50";"'<'";"15.0";"nM";"";"";"429064";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3898354";"";"None";"462.51";"0";"3.64";"BDBM245983";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CC[C@H](F)C4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429066";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3650710";"";"None";"346.39";"0";"3.66";"BDBM148094";"Cc1cc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)on1";"IC50";"'<'";"300.0";"nM";"";"";"286080";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650701";"";"None";"440.56";"0";"3.51";"BDBM148085";"CN1CCN(c2ccc(Nc3nccc(-c4ccc(N5CCCC5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286072";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4552628";"";"None";"425.89";"0";"3.66";"27";"Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4479785";"Inhibition of full-length recombinant human GST-tagged TBK1 expressed in insect cells by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4521346";"";"None";"434.50";"0";"2.17";"7";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CCO)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"5110.0";"nM";"5.29";"";"";"UO_0000065";"12.18";"0.23";"3.12";"4.44";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3926764";"";"None";"503.54";"1";"2.10";"BDBM246080";"N#Cc1nc(-c2ccnc(Nc3ccc(NC(=O)CN4CC[C@H](F)C4)nc3)n2)ccc1N1CC[C@H](O)C1";"IC50";"'<'";"30.0";"nM";"";"";"429163";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906947";"";"None";"436.54";"0";"2.30";"BDBM205171";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"300.0";"nM";"6.52";"";"363251";"UO_0000065";"14.94";"0.29";"4.22";"6.24";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980051";"";"None";"465.58";"0";"3.75";"BDBM205209";"CN(C)C(=O)CCCCCc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"580.0";"nM";"6.24";"";"363276";"UO_0000065";"13.40";"0.26";"2.49";"5.27";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4282790";"";"None";"388.40";"0";"1.91";"150";"Nc1nc2oc3ccc(C4CCS(=O)(=O)CC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"15.66";"0.31";"4.17";"4.33";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4291966";"";"None";"360.38";"0";"3.06";"169";"Nc1nc2oc3ccc(C4=CCCCC4)cc3c(=O)c2cc1-c1nn[nH]n1";"IC50";"'='";"489.78";"nM";"6.31";"";"";"UO_0000065";"17.51";"0.32";"3.25";"5.11";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3650724";"";"None";"385.43";"0";"4.06";"BDBM148108";"N#Cc1cc(-c2ccnc(Nc3cccc(C(=O)O)c3)n2)ccc1N1CCCC1";"IC50";"'<'";"30.0";"nM";"";"";"286089";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650723";"";"None";"388.44";"0";"2.19";"BDBM148107";"Cn1nc(C(N)=O)cc1Nc1nccc(-c2ccc(N3CCCC3)c(C#N)c2)n1";"IC50";"'<'";"300.0";"nM";"";"";"286088";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650702";"";"None";"385.48";"0";"3.82";"BDBM148086";"CN(C)c1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286073";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687148";"";"None";"458.57";"0";"4.38";"BDBM144182";"CN1CCC(n2cc(Nc3cc(-c4ccc(OC5CCOCC5)c(C#N)c4)ccn3)cn2)CC1";"IC50";"'='";"83.0";"nM";"7.08";"";"280334";"UO_0000065";"15.44";"0.28";"2.70";"8.03";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687157";"";"None";"373.42";"0";"3.71";"BDBM144191";"N#Cc1cc(-c2ccnc(Nc3ncccn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"670.0";"nM";"6.17";"";"280343";"UO_0000065";"16.53";"0.30";"2.46";"6.64";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687158";"";"None";"402.45";"0";"3.81";"BDBM144192";"N#Cc1cc(-c2ccnc(Nc3ccc(CO)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"14.0";"nM";"7.85";"";"280344";"UO_0000065";"19.52";"0.36";"4.04";"7.83";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687159";"";"None";"444.54";"0";"4.04";"BDBM144193";"N#Cc1cc(-c2ccnc(Nc3cnn(C4CCNCC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"71.0";"nM";"7.15";"";"280345";"UO_0000065";"16.08";"0.30";"3.11";"7.37";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687181";"";"None";"431.50";"0";"3.05";"BDBM144215";"N#Cc1cc(-c2ccnc(Nc3cnn(C4CCNC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"7.0";"nM";"8.15";"";"280367";"UO_0000065";"18.90";"0.35";"5.10";"7.42";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682430";"";"None";"455.56";"0";"4.78";"BDBM144137";"N#Cc1cc(-c2ccnc(Nc3cc(C4CCNCC4)ccn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"280383";"UO_0000065";"19.10";"0.35";"3.92";"9.45";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687143";"";"None";"439.56";"1";"5.33";"BDBM144177";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cn3)c2)ccc1CCC1CCC1";"IC50";"'='";"54.0";"nM";"7.27";"";"280422";"UO_0000065";"16.53";"0.30";"1.94";"9.81";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3934112";"";"None";"313.34";"0";"1.88";"BDBM205235";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc[nH]1";"IC50";"'='";"120.0";"nM";"6.92";"";"363293";"UO_0000065";"22.09";"0.43";"5.04";"6.08";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125723";"";"None";"452.58";"0";"3.38";"23";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(C(N)=S)cnc3[nH]2)cc1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"16.21";"0.31";"3.96";"6.22";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3936393";"";"None";"357.38";"0";"2.56";"BDBM209658";"Nc1ncc(-c2cccc(-n3cccn3)c2)cc1C(=O)Nc1ccnnc1";"IC50";"'='";"790.0";"nM";"6.10";"";"370548";"UO_0000065";"17.08";"0.31";"3.54";"5.47";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953248";"";"None";"352.40";"0";"2.13";"BDBM209660";"COCCn1cc(-c2cnc(N)c(C(=O)Nc3ccnc(C)c3)c2)cn1";"IC50";"'='";"1200.0";"nM";"5.92";"";"370550";"UO_0000065";"16.80";"0.31";"3.79";"5.48";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925708";"";"None";"435.51";"0";"3.62";"BDBM209669";"Nc1ncc(-c2ccc(CN3CCOCC3)s2)cc1C(=O)Nc1ccnc2ccoc12";"IC50";"'='";"890.0";"nM";"6.05";"";"370559";"UO_0000065";"13.89";"0.27";"2.43";"5.68";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3922312";"";"None";"395.49";"0";"2.87";"BDBM209683";"Nc1ncc(-c2csc(CN3CCOCC3)c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"140.0";"nM";"6.85";"";"370571";"UO_0000065";"17.33";"0.33";"3.98";"7.34";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2011941";"";"None";"555.52";"1";"4.97";"4p";"O=C(NCCCNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12)C1CCC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.12";"0.32";"3.43";"8.82";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011943";"";"None";"436.52";"0";"2.84";"5b";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(C(N)=O)cnc3[nH]2)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"18.43";"0.34";"5.21";"5.96";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL288441";"BOSUTINIB";"4.0";"530.46";"2";"5.19";"SKI-606";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"IC50";"'='";"471.0";"nM";"6.33";"";"";"UO_0000065";"11.93";"0.24";"1.14";"7.63";"0";"CHEMBL1244348";"Inhibition of TBK1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240341";"1";"Scientific Literature";"Leukemia";"2009";"None";"";""
"CHEMBL3650731";"";"None";"442.53";"0";"3.25";"BDBM148115";"CN(C)CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286096";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3963738";"";"None";"427.51";"0";"3.59";"BDBM245933";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cnc1N1CCCC1";"IC50";"'<'";"15.0";"nM";"";"";"429016";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3920382";"";"None";"486.56";"0";"3.09";"BDBM245934";"CN1CCN(C(=O)c2cccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)c2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"429017";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952082";"";"None";"496.57";"0";"2.23";"BDBM246001";"CS(=O)(=O)CCNCc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429084";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921247";"";"None";"489.52";"0";"2.53";"BDBM246027";"N#Cc1cc(-c2nc(Nc3ccnc(NC(=O)CN4CCOCC4)c3)ncc2F)cnc1NC1CC1";"IC50";"'<'";"100.0";"nM";"";"";"429110";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3969564";"";"None";"456.55";"0";"3.74";"BDBM246068";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1NC1CCCC1";"IC50";"'<'";"100.0";"nM";"";"";"429151";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4291966";"";"None";"360.38";"0";"3.06";"169";"Nc1nc2oc3ccc(C4=CCCCC4)cc3c(=O)c2cc1-c1nn[nH]n1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"17.51";"0.32";"3.25";"5.11";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3745885";"";"None";"467.46";"0";"3.66";"7ao; ON1231320";"Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750179";"Inhibition of human TBK1 using [KRRRAL[pS]VASLPGL] as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745707";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL3639495";"";"None";"427.51";"0";"3.59";"BDBM148082";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)ccc1N1CCCC1";"IC50";"'<'";"30.0";"nM";"";"";"286070";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125742";"";"None";"332.39";"0";"4.23";"11";"COc1ccc(-c2nc3cc(-c4csc(C#N)c4)cnc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4276661";"";"None";"336.35";"0";"3.58";"126";"Nc1nc2oc3ccc(C4=CCCCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"17.15";"0.32";"2.19";"5.42";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4289613";"";"None";"381.39";"0";"2.35";"146";"CC(=O)N1CCC(c2ccc3oc4nc(N)c(C(=O)O)cc4c(=O)c3c2)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"17.22";"0.32";"4.22";"5.18";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"34; BAY-985";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.71";"0.30";"4.32";"8.19";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4566796";"";"None";"554.58";"1";"4.46";"30";"COCc1cc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"16.51";"0.31";"4.69";"8.16";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4577511";"";"None";"514.51";"1";"4.22";"16";"Cc1noc(-c2ccc3nc(Nc4cc([C@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"13.56";"0.26";"2.75";"6.01";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4573638";"";"None";"472.55";"0";"3.50";"13";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)C6CCC6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"146.0";"nM";"6.84";"";"";"UO_0000065";"14.47";"0.27";"3.34";"5.89";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4545291";"";"None";"490.57";"0";"4.11";"4";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)OC(C)(C)C)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"273.0";"nM";"6.56";"";"";"UO_0000065";"13.38";"0.25";"2.45";"5.24";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4459120";"";"None";"443.43";"0";"3.17";"1";"N#Cc1ccc2nc(Nc3cc(CN4CCN(C(=O)CC(F)(F)F)CC4)ccn3)[nH]c2c1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"17.00";"0.32";"4.37";"7.47";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4450510";"";"None";"458.53";"0";"3.11";"11";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)C6CC6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"1270.0";"nM";"5.90";"";"";"UO_0000065";"12.86";"0.24";"2.79";"5.08";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4553949";"";"None";"514.51";"1";"4.22";"17";"Cc1noc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"372.0";"nM";"6.43";"";"";"UO_0000065";"12.50";"0.24";"2.21";"5.54";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4524534";"";"None";"514.47";"1";"3.30";"18";"Cc1noc(-c2ccc3nc(Nc4cc(C(=O)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4453292";"";"None";"539.57";"1";"3.82";"33";"CN(C)c1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"167.0";"nM";"6.78";"";"";"UO_0000065";"12.56";"0.24";"2.96";"6.38";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4446892";"";"None";"520.34";"1";"3.31";"GSK8612";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"11.72";"0.27";"2.79";"4.77";"0";"CHEMBL4364415";"Inhibition of TBK1 in TLR3-stimulated human PBMC assessed as decrease in poly(I:C)-induced IFNalpha secretion preincubated for 1 hr followed by poly(I:C) addition and measured after 16 hrs by FACS based cytometric bead array method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364239";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";""
"CHEMBL2011911";"";"None";"318.18";"0";"3.01";"2i";"CNc1c(Br)cnc2[nH]c(-c3ccc(N)cc3)nc12";"IC50";"'='";"111.0";"nM";"6.96";"";"";"UO_0000065";"21.86";"0.50";"3.94";"8.73";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011915";"";"None";"388.27";"0";"3.27";"2m";"CNc1c(Br)cnc2[nH]c(-c3ccc(N4CCOCC4)cc3)nc12";"IC50";"'='";"213.0";"nM";"6.67";"";"";"UO_0000065";"17.18";"0.38";"3.40";"10.10";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011916";"";"None";"446.35";"0";"3.53";"2n";"CNc1c(Br)cnc2[nH]c(-c3ccc(OCCCN4CCOCC4)cc3)nc12";"IC50";"'='";"233.0";"nM";"6.63";"";"";"UO_0000065";"14.86";"0.32";"3.10";"8.81";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011919";"";"None";"472.39";"0";"2.41";"2q";"CNc1c(Br)cnc2[nH]c(-c3ccc(C(=O)NCCN4CCN(C)CC4)cc3)nc12";"IC50";"'='";"196.0";"nM";"6.71";"";"";"UO_0000065";"14.20";"0.31";"4.30";"7.52";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011925";"";"None";"353.43";"0";"2.38";"3c";"CNc1ccnc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc12";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"13.92";"0.26";"2.54";"6.53";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011928";"";"None";"418.30";"0";"3.33";"4c";"COc1ccc(-c2nc3c(NCCCNC(C)=O)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"17.10";"0.38";"3.82";"7.78";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011929";"";"None";"446.35";"0";"3.97";"4d";"COc1ccc(-c2nc3c(NCCCNC(=O)C(C)C)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.92";"0.39";"4.03";"8.70";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2010815";"";"None";"476.35";"0";"4.25";"5e";"COc1cc(F)ccc1-c1nc2c(NCCCNC(=O)C3CCC3)c(Br)cnc2[nH]1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"15.58";"0.34";"3.17";"8.07";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3650739";"";"None";"485.60";"0";"2.83";"BDBM148123";"CN(C)CCNc1ccc(Nc2nccc(-c3ccc(N4CCC(C(N)=O)CC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"300.0";"nM";"";"";"286104";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650717";"";"None";"442.57";"0";"3.75";"BDBM148101";"CN(C)CCN(C)c1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286084";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650693";"";"None";"419.51";"0";"3.76";"BDBM148076";"CS(=O)(=O)c1cccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)c1";"IC50";"'<'";"30.0";"nM";"";"";"286067";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2333365";"";"None";"455.51";"0";"3.22";"28, XL388";"Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2345764";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2331117";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3125738";"";"None";"351.39";"0";"4.06";"7";"COc1ccc(-c2nc3cc(-c4ccc(C(=O)O)s4)cnc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL2011921";"";"None";"343.19";"0";"3.31";"2s";"CNc1c(Br)cnc2[nH]c(-c3ccc4[nH]ncc4c3)nc12";"IC50";"'='";"288.0";"nM";"6.54";"";"";"UO_0000065";"19.06";"0.43";"3.23";"7.95";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011924";"";"None";"387.87";"0";"3.03";"3b";"CNc1c(Cl)cnc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc12";"IC50";"'='";"383.0";"nM";"6.42";"";"";"UO_0000065";"16.54";"0.32";"3.39";"8.52";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011931";"";"None";"444.33";"0";"3.72";"4f";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"17.43";"0.38";"4.02";"8.42";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4582703";"";"None";"533.63";"2";"3.60";"Amgen compound II";"COc1ccc(-n2ncc3cnc(Nc4cc(OC)c(OC)c(OCCCN5CCN(C)CC5)c4)nc32)cc1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.78";"0.28";"4.29";"7.96";"0";"CHEMBL4373769";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL3687163";"";"None";"472.59";"0";"4.51";"BDBM144197";"N#Cc1cc(-c2ccnc(Nc3cnn(CCC4CCNCC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"70.0";"nM";"7.16";"";"280349";"UO_0000065";"15.14";"0.28";"2.64";"7.37";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687166";"";"None";"440.51";"0";"4.28";"BDBM144200";"N#Cc1cc(-c2ccnc(Nc3cnn(CC4CC4C#N)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"110.0";"nM";"6.96";"";"280352";"UO_0000065";"15.80";"0.29";"2.68";"6.40";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687171";"";"None";"530.63";"1";"3.74";"BDBM144205";"N#Cc1cc(-c2ccnc(Nc3cnn(CCC4CCN(C(=O)CO)CC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"120.0";"nM";"6.92";"";"280357";"UO_0000065";"13.04";"0.24";"3.18";"5.51";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687112";"";"None";"457.53";"0";"4.15";"BDBM144145";"N#Cc1cc(-c2ccnc(Nc3cc(N4CCOCC4)ccn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"230.0";"nM";"6.64";"";"280391";"UO_0000065";"14.51";"0.27";"2.49";"7.17";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687147";"";"None";"512.61";"1";"4.91";"BDBM144181";"[C-]#[N+]c1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cn3)c2)ccc1OCC1CCN(C(C)=O)CC1";"IC50";"'='";"810.0";"nM";"6.09";"";"280426";"UO_0000065";"11.88";"0.22";"1.18";"7.24";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687161";"";"None";"454.49";"0";"4.77";"BDBM144195";"N#Cc1cc(-c2ccnc(Nc3ccc4oc(C(N)=O)cc4c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"1900.0";"nM";"5.72";"";"280347";"UO_0000065";"12.59";"0.23";"0.95";"4.64";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687168";"";"None";"445.52";"0";"3.75";"BDBM144202";"N#Cc1cc(-c2ccnc(Nc3cnn(C[C@H]4C[C@@H]4CO)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"18.0";"nM";"7.75";"";"280354";"UO_0000065";"17.38";"0.32";"3.99";"7.36";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687110";"";"None";"377.40";"0";"3.61";"BDBM144143";"Cc1cc(Nc2nccc(-c3ccc(OC4CCOCC4)c(C#N)c3)n2)no1";"IC50";"'='";"230.0";"nM";"6.64";"";"280389";"UO_0000065";"17.59";"0.32";"3.03";"6.26";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2011895";"";"None";"430.35";"0";"4.29";"1a";"CNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12";"IC50";"'='";"151.0";"nM";"6.82";"";"";"UO_0000065";"15.85";"0.35";"2.53";"10.32";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL103667";"DORAMAPIMOD";"2.0";"527.67";"2";"5.99";"2, BIRB-796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1931564";"Inhibition of TBK1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926590";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL4277195";"";"None";"297.27";"0";"2.05";"112";"C=C(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cn1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"19.17";"0.35";"3.65";"4.78";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4295050";"";"None";"326.35";"0";"3.21";"117";"CC(C)CCc1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"18.63";"0.35";"2.87";"5.71";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4278101";"";"None";"296.28";"0";"2.50";"122";"Nc1nc2oc3ccc(C4CC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"19.03";"0.35";"3.14";"5.30";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4290024";"";"None";"340.34";"0";"2.52";"147";"Nc1nc2oc3ccc(C4CCOCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"18.00";"0.33";"3.60";"5.30";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL2207192";"";"None";"432.53";"0";"4.47";"16a";"O=C(NCCCNc1nc(Nc2cccc(-c3cnco3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.40";"0.34";"3.49";"7.58";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4245507";"";"None";"437.57";"0";"3.06";"28";"O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4233415";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229420";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3650743";"";"None";"470.54";"0";"3.07";"BDBM148127";"CNC(=O)C1CCN(c2ccc(-c3ccnc(Nc4ccc(NC(C)=O)nc4)n3)cc2C#N)CC1";"IC50";"'<'";"300.0";"nM";"";"";"286108";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650728";"";"None";"415.46";"0";"2.95";"BDBM148112";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CCOCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286093";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650718";"";"None";"412.50";"0";"4.34";"BDBM148102";"CC(=O)N(C)c1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cc1";"IC50";"'<'";"30.0";"nM";"";"";"286085";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4069365";"";"None";"421.38";"0";"4.14";"13";"CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21";"IC50";"'='";"7610.0";"nM";"5.12";"";"";"UO_0000065";"12.15";"0.23";"0.98";"5.05";"0";"CHEMBL4007750";"Inhibition of TBK1 (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL2207179";"";"None";"472.36";"0";"4.67";"10f";"O=C(CCc1ccccc1)NCCCNc1nc(Nc2cccc(F)c2)ncc1Br";"IC50";"'='";"560.0";"nM";"6.25";"";"";"UO_0000065";"13.24";"0.28";"1.58";"7.92";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207221";"";"None";"529.41";"1";"4.19";"10d";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)c1cccc(N2CCOCC2)c1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.28";"0.22";"1.25";"5.96";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207219";"";"None";"426.29";"0";"3.08";"10b";"COCCC(=O)NCCCNc1nc(Nc2cccc(F)c2)ncc1Br";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"16.94";"0.38";"4.14";"8.19";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3125740";"";"None";"335.32";"0";"3.59";"9";"COc1ccc(-c2nc3cc(-c4cc(C(=O)O)co4)cnc3[nH]2)cc1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"17.83";"0.33";"2.39";"5.91";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4288542";"";"None";"365.35";"0";"0.94";"171";"Nc1nc2oc3ccc(N4CCOCC4)cc3c(=O)c2cc1-c1nn[nH]n1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"17.16";"0.32";"5.33";"4.61";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4277887";"";"None";"408.38";"0";"0.53";"172";"Nc1nc2oc3ccc(N4CCOCC4)cc3c(=O)c2cc1C(=O)Nc1nn[nH]n1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"14.98";"0.28";"5.59";"3.71";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4277614";"";"None";"296.28";"0";"2.65";"105";"C=C(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"1348.96";"nM";"5.87";"";"";"UO_0000065";"19.81";"0.36";"3.22";"5.52";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4290544";"";"None";"312.33";"0";"2.82";"116";"CC(C)Cc1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"2818382.93";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL2207187";"";"None";"383.47";"0";"3.96";"14";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"21.11";"0.39";"4.14";"10.26";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3125721";"";"None";"519.63";"1";"3.96";"25";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(N)=O)cs4)cnc3[nH]2)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"15.69";"0.30";"4.19";"5.51";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125724";"";"None";"520.61";"2";"5.14";"22";"COc1ccc(-c2nc3c(OCCCNC(=O)C4CCCC4)c(-c4csc(C(=O)O)c4)cnc3[nH]2)cc1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"12.17";"0.23";"1.20";"5.01";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4446892";"";"None";"520.34";"1";"3.31";"GSK8612";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"1258.93";"nM";"5.90";"";"";"UO_0000065";"11.34";"0.26";"2.59";"4.62";"0";"CHEMBL4364417";"Inhibition of TBK1 in human THP1 cells assessed as decrease in baculovirus-stimulated IFNbeta secretion preincubated for 45 mins followed by virus addition and measured after 20 hrs by electrochemiluminescence method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364239";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";""
"CHEMBL3650737";"";"None";"444.54";"0";"2.70";"BDBM148121";"CN(C)CCNc1ccc(Nc2nccc(-c3ccc(N4CC[C@H](O)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286102";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125732";"";"None";"350.40";"0";"3.46";"14";"COc1ccc(-c2nc3cc(-c4csc(C(N)=O)c4)cnc3[nH]2)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"21.47";"0.41";"4.06";"8.01";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125727";"";"None";"406.51";"0";"4.75";"19";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"18.28";"0.35";"2.68";"9.30";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3687149";"";"None";"376.42";"0";"4.22";"BDBM144183";"Cc1cc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ccn2)no1";"IC50";"'='";"34.0";"nM";"7.47";"";"280335";"UO_0000065";"19.84";"0.36";"3.25";"8.01";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682427";"";"None";"456.55";"0";"4.18";"BDBM144134";"N#Cc1cc(-c2ccnc(Nc3ccc(C4CCNCC4)nn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"21.0";"nM";"7.68";"";"280380";"UO_0000065";"16.82";"0.31";"3.50";"7.31";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687116";"";"None";"454.53";"1";"5.47";"BDBM144149";"N#Cc1cc(-c2ccnc(Nc3cc(C4=CCCCO4)ccn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"290.0";"nM";"6.54";"";"280395";"UO_0000065";"14.38";"0.26";"1.07";"7.32";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3919338";"";"None";"445.51";"0";"2.51";"BDBM245953";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCNCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429036";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110039";"";"None";"457.54";"0";"1.92";"BDBM245954";"C[C@@H]1CN(c2ccc(Nc3nccc(-c4cnc(N5CC[C@H](O)C5)c(C#N)c4)n3)cn2)CCN1";"IC50";"'<'";"30.0";"nM";"";"";"429037";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895745";"";"None";"461.51";"0";"2.77";"BDBM245965";"CC(C)(N)C(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429048";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL373751";"GSK-319347A";"None";"469.54";"0";"3.96";"1";"COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"14.98";"0.30";"3.07";"6.80";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL2011936";"";"None";"472.39";"0";"4.50";"4";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.94";"0.36";"3.50";"8.70";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4568087";"";"None";"421.53";"0";"2.86";"19";"Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4479785";"Inhibition of full-length recombinant human GST-tagged TBK1 expressed in insect cells by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4251324";"";"None";"436.58";"0";"4.54";"30";"O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4233363";"Inhibition of NAK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229420";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3650692";"";"None";"398.47";"0";"4.32";"BDBM148075";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cc1";"IC50";"'<'";"30.0";"nM";"";"";"286066";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650712";"";"None";"345.41";"0";"3.09";"BDBM148096";"Cn1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)n1";"IC50";"'<'";"300.0";"nM";"";"";"286082";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4521346";"";"None";"434.50";"0";"2.17";"7";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CCO)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"1060.0";"nM";"5.97";"";"";"UO_0000065";"13.75";"0.25";"3.80";"5.01";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4549459";"";"None";"500.49";"1";"3.66";"3";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"129.0";"nM";"6.89";"";"";"UO_0000065";"13.77";"0.26";"3.23";"5.94";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4436416";"";"None";"498.51";"0";"3.70";"21";"Cn1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)cn1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"11.39";"0.22";"1.98";"5.98";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3125735";"";"None";"442.52";"0";"4.85";"3";"O=C(O)c1ccc(-c2cnc3[nH]c(-c4ccc(OCCN5CCCCC5)cc4)nc3c2)cc1";"IC50";"'='";"859.0";"nM";"6.07";"";"";"UO_0000065";"13.71";"0.25";"1.22";"6.64";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL1761512";"";"None";"425.55";"0";"3.85";"14a";"CCCS(=O)(=O)N1CCC(c2c[nH]c3c(C(N)=O)cc(-c4ccccc4)cc23)CC1";"IC50";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1764210";"Inhibition of TBK-1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759890";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2205766";"";"None";"346.42";"0";"1.45";"14, CZC24758";"CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2214457";"Inhibition of TBK1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203257";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3896126";"";"None";"451.55";"0";"3.36";"BDBM205199";"CN(C)C(=O)CCCCc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"99.0";"nM";"7.00";"";"363266";"UO_0000065";"15.51";"0.30";"3.64";"5.92";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955705";"";"None";"438.51";"0";"3.74";"BDBM205202";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(CCCCCC(=O)O)cc1";"IC50";"'='";"160.0";"nM";"6.80";"";"363269";"UO_0000065";"15.50";"0.30";"3.06";"5.02";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929152";"";"None";"463.56";"0";"3.36";"BDBM205204";"CC(=O)N1CCC(Cc2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"363271";"UO_0000065";"14.45";"0.28";"3.34";"5.66";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3951104";"";"None";"450.52";"0";"1.94";"BDBM205208";"CN1CCN(C(=O)c2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"363275";"UO_0000065";"14.45";"0.28";"4.57";"5.36";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3914507";"";"None";"420.45";"0";"3.32";"BDBM246028";"COCCNc1cc(Nc2ncc(F)c(-c3cnc(NC4CC4)c(C#N)c3)n2)ccn1";"IC50";"'<'";"100.0";"nM";"";"";"429111";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4293403";"";"None";"356.40";"0";"3.23";"149";"Nc1nc2oc3ccc(C4CCSCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"18.34";"0.36";"3.31";"6.14";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL2011933";"";"None";"458.36";"0";"4.11";"2";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.32";"0.40";"4.29";"9.14";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3687162";"";"None";"425.44";"0";"4.38";"BDBM144196";"N#Cc1cc(-c2ccnc(Nc3cnn(CC(F)F)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"55.0";"nM";"7.26";"";"280348";"UO_0000065";"17.06";"0.32";"2.88";"8.54";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682433";"";"None";"401.47";"0";"3.78";"BDBM144140";"N#Cc1cc(-c2ccnc(Nc3cc(CN)ccn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"30.0";"nM";"7.52";"";"280386";"UO_0000065";"18.74";"0.34";"3.74";"7.09";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687121";"";"None";"455.56";"0";"4.78";"BDBM144154";"N#Cc1cc(-c2ccnc(Nc3cccc(C4CCNCC4)n3)c2)ccc1OC1CCOCC1";"IC50";"'='";"32.0";"nM";"7.50";"";"280400";"UO_0000065";"16.45";"0.30";"2.71";"8.14";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2011944";"";"None";"474.36";"0";"3.09";"5c";"COc1ccccc1-c1nc2c(NCC(O)CNC(=O)C3CCC3)c(Br)cnc2[nH]1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"15.80";"0.34";"4.40";"6.68";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207216";"";"None";"480.66";"0";"4.06";"20j";"CC(C)N1CCC(n2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)cn2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"16.97";"0.32";"4.09";"8.15";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207204";"";"None";"460.63";"0";"4.34";"19a";"O=C(NCCCNc1nc(Nc2ccc3c(c2)CN(C2CC2)CC3)ncc1C1CC1)C1CCC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"17.70";"0.33";"3.81";"9.92";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207203";"";"None";"367.46";"0";"2.61";"18d";"O=C(NCCCNc1nc(Nc2cncnc2)ncc1C1CC1)C1CCC1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"14.95";"0.28";"2.88";"5.25";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207182";"";"None";"465.37";"0";"3.38";"10i";"CN1CCC(C(=O)NCCCNc2nc(Nc3cccc(F)c3)ncc2Br)CC1";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"11.53";"0.25";"1.99";"6.53";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207218";"";"None";"450.34";"0";"4.42";"10a";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)c1cccs1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.87";"0.41";"3.63";"10.19";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207217";"";"None";"544.48";"1";"4.90";"9";"O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br)c1cccs1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.10";"0.33";"3.32";"7.39";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3125728";"";"None";"420.54";"1";"5.14";"18";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1";"IC50";"'='";"143.0";"nM";"6.84";"";"";"UO_0000065";"16.28";"0.31";"1.70";"8.57";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125732";"";"None";"350.40";"0";"3.46";"14";"COc1ccc(-c2nc3cc(-c4csc(C(N)=O)c4)cnc3[nH]2)cc1";"IC50";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"18.76";"0.36";"3.11";"7.00";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125730";"";"None";"436.54";"0";"4.11";"16";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)CO)c4)cnc3[nH]2)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.04";"0.31";"2.89";"6.99";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4289613";"";"None";"381.39";"0";"2.35";"146";"CC(=O)N1CCC(c2ccc3oc4nc(N)c(C(=O)O)cc4c(=O)c3c2)CC1";"IC50";"'='";"16982.44";"nM";"4.77";"";"";"UO_0000065";"12.51";"0.23";"2.42";"3.76";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3963569";"";"None";"470.99";"0";"2.96";"BDBM205172";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccnc(Cl)c4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"363252";"UO_0000065";"12.43";"0.25";"2.89";"5.60";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921400";"";"None";"504.54";"1";"3.32";"BDBM205175";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccnc(C(F)(F)F)c4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"6300.0";"nM";"5.20";"";"363255";"UO_0000065";"10.31";"0.20";"1.88";"4.98";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3944901";"";"None";"454.53";"0";"2.44";"BDBM205193";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4F)nc3C(N)=O)cc2)CC1";"IC50";"'='";"370.0";"nM";"6.43";"";"363260";"UO_0000065";"14.15";"0.27";"3.99";"6.16";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906947";"";"None";"436.54";"0";"2.30";"BDBM205171";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"710.0";"nM";"6.15";"";"363278";"UO_0000065";"14.09";"0.27";"3.85";"5.89";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919767";"";"None";"367.43";"0";"2.62";"BDBM205231";"CN(C)c1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"363289";"UO_0000065";"15.63";"0.30";"3.12";"5.68";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4293403";"";"None";"356.40";"0";"3.23";"149";"Nc1nc2oc3ccc(C4CCSCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"489778.82";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4281345";"";"None";"323.32";"0";"1.17";"170";"CN(C)c1ccc2oc3nc(N)c(-c4nn[nH]n4)cc3c(=O)c2c1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"19.41";"0.36";"5.11";"4.95";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4285560";"";"None";"298.30";"0";"2.75";"106";"CC(C)c1ccc2c(=O)c3cc(C(=O)O)c(N)nc3oc2c1";"IC50";"'='";"302.0";"nM";"6.52";"";"";"UO_0000065";"21.86";"0.40";"3.77";"6.13";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4288939";"";"None";"298.30";"0";"2.75";"108";"CC(C)c1cccc2oc3nc(N)c(C(=O)O)cc3c(=O)c12";"IC50";"'='";"1096.48";"nM";"5.96";"";"";"UO_0000065";"19.98";"0.37";"3.21";"5.60";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3977169";"";"None";"505.53";"1";"3.08";"BDBM245972";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CN4CC[C@H](F)C4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429055";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915896";"";"None";"474.54";"0";"3.32";"BDBM245982";"C[C@H]1COCCN1Cc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429065";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3903354";"";"None";"464.51";"0";"2.97";"BDBM245998";"COCCNc1cc(Nc2ncc(F)c(-c3cnc(N4CCCOCC4)c(C#N)c3)n2)ccn1";"IC50";"'<'";"100.0";"nM";"";"";"429081";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918874";"";"None";"490.50";"0";"2.41";"BDBM246009";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4C(=O)OCC4CO)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429092";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3908778";"";"None";"428.50";"0";"2.96";"BDBM246025";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1NC1CC1";"IC50";"'<'";"100.0";"nM";"";"";"429108";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3687136";"";"None";"372.43";"0";"4.04";"BDBM144170";"N#Cc1cc(-c2ccnc(Nc3ccc(CO)cn3)c2)ccc1OCC1CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"280415";"UO_0000065";"19.84";"0.36";"3.35";"8.11";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4451595";"";"None";"538.58";"1";"4.43";"27";"CN(C)c1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ccn1";"IC50";"'='";"388.0";"nM";"6.41";"";"";"UO_0000065";"11.90";"0.22";"1.98";"6.87";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3125734";"";"None";"349.42";"0";"4.56";"12";"COc1ccc(-c2nc3cc(-c4csc(C(C)=O)c4)cnc3[nH]2)cc1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"17.71";"0.34";"1.63";"9.12";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL2011933";"";"None";"458.36";"0";"4.11";"2";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"17.94";"0.39";"4.11";"8.94";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3901254";"";"None";"504.54";"1";"3.32";"BDBM205188";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4C(F)(F)F)nc3C(N)=O)cc2)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"363258";"UO_0000065";"11.60";"0.23";"2.53";"5.60";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3934866";"";"None";"450.57";"0";"2.61";"BDBM205196";"Cc1cnccc1-c1nc(C(N)=O)c(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)s1";"IC50";"'='";"350.0";"nM";"6.46";"";"363263";"UO_0000065";"14.33";"0.28";"3.85";"6.18";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3951517";"";"None";"411.49";"0";"2.29";"BDBM205207";"COCCNCc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"260.0";"nM";"6.58";"";"363274";"UO_0000065";"16.00";"0.31";"4.30";"5.52";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4281788";"";"None";"352.35";"0";"2.85";"140";"Nc1nc2oc3ccc(C4CCC(=O)CC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"18.01";"0.33";"3.50";"5.14";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3650754";"";"None";"470.58";"0";"3.23";"BDBM148138";"CN1CCC(Nc2ccc(Nc3nccc(-c4ccc(N5CC[C@H](O)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286119";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125738";"";"None";"351.39";"0";"4.06";"7";"COc1ccc(-c2nc3cc(-c4ccc(C(=O)O)s4)cnc3[nH]2)cc1";"IC50";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"18.76";"0.36";"2.53";"7.48";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL373751";"GSK-319347A";"None";"469.54";"0";"3.96";"KIN001-135";"COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"15.21";"0.30";"3.18";"6.91";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125741";"";"None";"351.39";"0";"4.06";"10";"COc1ccc(-c2nc3cc(-c4csc(C(=O)O)c4)cnc3[nH]2)cc1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"20.80";"0.40";"3.25";"8.30";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL2207201";"";"None";"451.58";"0";"3.05";"18b";"O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)nc2)ncc1C1CC1)C1CCC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"17.33";"0.32";"4.77";"7.50";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207193";"";"None";"450.59";"0";"3.65";"16b";"O=C(NCCCNc1nc(Nc2cccc(N3CCOCC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"16.76";"0.31";"3.90";"8.26";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207183";"";"None";"493.38";"0";"3.30";"10j";"CC(=O)N1CCC(C(=O)NCCCNc2nc(Nc3cccc(F)c3)ncc2Br)CC1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"12.90";"0.28";"3.07";"6.41";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207213";"";"None";"423.57";"0";"4.13";"20g";"O=C(NCCCNc1nc(Nc2cnn(C3CCCC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.83";"0.37";"4.27";"8.68";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207209";"";"None";"397.53";"0";"3.59";"20c";"CC(C)n1cc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cn1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.13";"0.40";"4.81";"8.68";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207197";"";"None";"462.64";"0";"4.63";"17c";"CN1CCC(c2ccc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)cc2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.50";"0.33";"3.47";"9.85";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207195";"";"None";"491.64";"0";"3.20";"17a";"CN1CCN(C(=O)c2ccc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)cc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"17.69";"0.33";"5.50";"8.49";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207191";"";"None";"399.56";"0";"4.39";"15d";"O=C(NCCCNc1nc(NC2CCCCC2)ncc1C1CC1)c1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207185";"";"None";"385.49";"0";"4.20";"12";"CC(C)c1cnc(Nc2cccc(F)c2)nc1NCCCNC(=O)C1CCC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207180";"";"None";"436.33";"0";"4.23";"10g";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)C1CCCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.56";"0.41";"3.87";"10.26";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011900";"";"None";"527.51";"2";"5.05";"1f";"Brc1cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1NCCC1CCNCC1";"IC50";"'='";"468.0";"nM";"6.33";"";"";"UO_0000065";"12.00";"0.25";"1.28";"8.10";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207186";"";"None";"397.50";"0";"4.03";"13";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1CC1CC1)C1CCC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4279379";"";"None";"299.29";"0";"1.69";"113";"CN(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"95499.26";"nM";"4.02";"";"";"UO_0000065";"13.43";"0.25";"2.33";"3.67";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4287304";"";"None";"338.36";"0";"3.67";"125";"Nc1nc2oc3ccc(C4CCCCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"19054607.18";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4281788";"";"None";"352.35";"0";"2.85";"140";"Nc1nc2oc3ccc(C4CCC(=O)CC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"630957.34";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3928914";"";"None";"356.39";"0";"3.16";"BDBM209641";"Nc1ncc(-c2cccc(-n3cccn3)c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"400.0";"nM";"6.40";"";"370534";"UO_0000065";"17.95";"0.32";"3.24";"6.48";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943325";"";"None";"409.52";"0";"3.18";"BDBM209645";"Cc1cc(NC(=O)c2cc(-c3ccc(CN4CCOCC4)s3)cnc2N)ccn1";"IC50";"'='";"78.0";"nM";"7.11";"";"370538";"UO_0000065";"17.36";"0.33";"3.93";"7.61";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924214";"";"None";"396.48";"0";"2.27";"BDBM209647";"Nc1ncc(-c2ccc(CN3CCOCC3)s2)nc1C(=O)Nc1ccncc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"370540";"UO_0000065";"15.13";"0.29";"3.73";"5.65";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980829";"";"None";"396.48";"0";"2.27";"BDBM209655";"Nc1ncc(-c2ccc(CN3CCOCC3)s2)cc1C(=O)Nc1ccnnc1";"IC50";"'='";"240.0";"nM";"6.62";"";"370546";"UO_0000065";"16.70";"0.32";"4.35";"6.23";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925343";"";"None";"462.53";"0";"3.18";"BDBM245985";"COCCN(C)Cc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429068";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968490";"";"None";"533.57";"2";"2.19";"BDBM245997";"N#Cc1cc(-c2nc(Nc3ccnc(NC(=O)CN4CCOCC4)c3)ncc2F)cnc1N1CCCOCC1";"IC50";"'<'";"100.0";"nM";"";"";"429080";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952708";"";"None";"402.44";"0";"2.70";"BDBM246013";"N#Cc1cc(-c2ccnc(Nc3cnc4c(c3)CNC4)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429096";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3936211";"";"None";"498.59";"0";"3.18";"BDBM246019";"CN1CCC(NC(=O)c2cccc(Nc3nccc(-c4cnc(NC5CCOC5)c(C#N)c4)n3)c2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"429102";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950198";"";"None";"362.40";"0";"2.09";"BDBM246020";"Cn1cc(Nc2nccc(-c3cnc(NC4CCOC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"429103";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3902062";"";"None";"499.58";"0";"2.23";"BDBM246055";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CCCC1CC(N)=O";"IC50";"'<'";"30.0";"nM";"";"";"429138";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3971527";"";"None";"486.58";"0";"2.85";"BDBM246059";"COCC1CCN(c2ncc(-c3ccnc(Nc4ccc(CN5CCOCC5)nc4)n3)cc2C#N)C1";"IC50";"'<'";"1000.0";"nM";"";"";"429142";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967014";"";"None";"407.50";"0";"3.15";"BDBM205212";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(CN2CCCC2)cc1";"IC50";"'='";"1160.0";"nM";"5.94";"";"363279";"UO_0000065";"14.57";"0.28";"2.79";"5.86";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947554";"";"None";"324.37";"0";"2.56";"BDBM205230";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccccc1";"IC50";"'='";"3600.0";"nM";"5.44";"";"363288";"UO_0000065";"16.78";"0.32";"2.88";"5.56";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3957230";"";"None";"503.54";"1";"2.37";"BDBM245962";"N#Cc1cc(-c2ccnc(Nc3ccnc(NC(=O)CN4CCOCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429045";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919184";"";"None";"489.56";"0";"2.84";"BDBM245970";"N#Cc1cc(-c2ccnc(Nc3ccc(NCCN4CCOCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429053";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3954664";"";"None";"515.58";"2";"1.41";"BDBM245978";"CN(C(=O)CN1CCOCC1)c1ccc(Nc2nccc(-c3cnc(N4CC[C@H](O)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"429061";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3896866";"";"None";"450.57";"0";"2.61";"BDBM205174";"Cc1cc(-c2nc(C(N)=O)c(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)s2)ccn1";"IC50";"'='";"410.0";"nM";"6.39";"";"363254";"UO_0000065";"14.18";"0.27";"3.78";"6.12";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3650729";"";"None";"428.50";"0";"2.86";"BDBM148113";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CCN(C)CC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"300.0";"nM";"";"";"286094";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4468020";"";"None";"538.58";"1";"4.57";"23";"O=C(CC(F)(F)F)N1CCN(Cc2ccnc(Nc3nc4ccc(-c5cnn(CC6CC6)c5)cc4[nH]3)c2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.41";"0.29";"3.73";"8.74";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4524534";"";"None";"514.47";"1";"3.30";"18";"Cc1noc(-c2ccc3nc(Nc4cc(C(=O)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"1210.0";"nM";"5.92";"";"";"UO_0000065";"11.50";"0.22";"2.62";"4.44";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4553949";"";"None";"514.51";"1";"4.22";"17";"Cc1noc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"15.01";"0.29";"3.50";"6.65";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4450510";"";"None";"458.53";"0";"3.11";"11";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)C6CC6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"148.0";"nM";"6.83";"";"";"UO_0000065";"14.89";"0.27";"3.72";"5.88";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4587843";"";"None";"454.49";"0";"3.44";"9";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CC(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"15.42";"0.29";"3.57";"7.08";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4566710";"";"None";"486.50";"0";"4.13";"8";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CCC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"281.0";"nM";"6.55";"";"";"UO_0000065";"13.47";"0.26";"2.42";"6.62";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL1929238";"";"None";"554.54";"2";"5.23";"27";"CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1931564";"Inhibition of TBK1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926590";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3892171";"";"None";"459.53";"0";"3.66";"BDBM246030";"COCCN1Cc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cc2C1";"IC50";"'<'";"15.0";"nM";"";"";"429113";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3972720";"";"None";"364.41";"0";"1.97";"BDBM246093";"COCCN(C)c1ccc(-c2ccnc(Nc3cnn(C)c3)n2)nc1C#N";"IC50";"'<'";"1000.0";"nM";"";"";"429176";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3930440";"";"None";"441.54";"0";"2.90";"BDBM245931";"CN1CCN(c2ccc(Nc3nccc(-c4cnc(N5CCCC5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"15.0";"nM";"";"";"429014";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921622";"";"None";"472.53";"0";"2.75";"BDBM245932";"N#Cc1cc(-c2ccnc(Nc3cccc(C(=O)N4CCNCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429015";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950694";"";"None";"362.40";"0";"1.46";"BDBM245944";"Cn1cc(Nc2nccc(-c3cnc(N4CC[C@H](O)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429027";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919474";"";"None";"503.54";"1";"2.37";"BDBM245945";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429028";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924783";"";"None";"434.44";"0";"2.03";"BDBM245955";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CO)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429038";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3923270";"";"None";"422.51";"0";"1.96";"BDBM205198";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(CN2CCNCC2)cc1";"IC50";"'='";"95.0";"nM";"7.02";"";"363265";"UO_0000065";"16.62";"0.32";"5.06";"6.20";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943590";"";"None";"435.55";"0";"3.44";"BDBM205200";"CN1CCC(Cc2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"363267";"UO_0000065";"16.07";"0.31";"3.56";"6.92";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3956700";"";"None";"424.53";"0";"2.21";"BDBM205205";"CN(C)CCNCc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"210.0";"nM";"6.68";"";"363272";"UO_0000065";"15.73";"0.30";"4.47";"5.90";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125726";"";"None";"420.54";"1";"5.14";"20";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"16.83";"0.32";"1.94";"8.86";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125730";"";"None";"436.54";"0";"4.11";"16";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)CO)c4)cnc3[nH]2)cc1";"IC50";"'='";"136.0";"nM";"6.87";"";"";"UO_0000065";"15.73";"0.30";"2.76";"6.86";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL2011903";"";"None";"333.19";"0";"3.44";"2a";"CNc1c(Br)cnc2[nH]c(-c3ccc(OC)cc3)nc12";"IC50";"'='";"335.0";"nM";"6.47";"";"";"UO_0000065";"19.43";"0.44";"3.03";"10.31";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011904";"";"None";"347.22";"0";"3.83";"2b";"CCOc1ccc(-c2nc3c(NC)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"231.0";"nM";"6.64";"";"";"UO_0000065";"19.11";"0.43";"2.81";"10.56";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011908";"";"None";"381.26";"0";"2.83";"2f";"CNc1c(Br)cnc2[nH]c(-c3ccc(S(C)(=O)=O)cc3)nc12";"IC50";"'='";"229.0";"nM";"6.64";"";"";"UO_0000065";"17.42";"0.41";"3.81";"7.57";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011909";"";"None";"381.26";"0";"2.83";"2g";"CNc1c(Br)cnc2[nH]c(-c3cccc(S(C)(=O)=O)c3)nc12";"IC50";"'='";"9550.0";"nM";"5.02";"";"";"UO_0000065";"13.17";"0.31";"2.19";"5.72";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011923";"";"None";"396.45";"0";"1.48";"3a";"CNc1c(C(N)=O)cnc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc12";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"17.13";"0.32";"5.31";"5.74";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011936";"";"None";"472.39";"0";"4.50";"4k";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.94";"0.36";"3.50";"8.70";"1";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3904190";"";"None";"463.49";"0";"3.68";"BDBM246087";"N#Cc1nc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2F)ccc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429170";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3911981";"";"None";"370.42";"0";"3.47";"BDBM209659";"Cc1cnccc1NC(=O)c1cc(-c2ccc(-n3cccn3)cc2)cnc1N";"IC50";"'='";"1000.0";"nM";"6.00";"";"370549";"UO_0000065";"16.20";"0.29";"2.53";"6.08";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5079149";"";"None";"546.45";"1";"3.87";"13";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)ncc2Br)cc1";"IC50";"'='";"192.0";"nM";"6.72";"";"";"UO_0000065";"12.29";"0.27";"2.85";"4.72";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL5089987";"";"None";"454.56";"0";"2.31";"19";"NS(=O)(=O)c1ccc(CNc2ccnc(Nc3cccc(CN4CCOCC4)c3)n2)cc1";"IC50";"'='";"2737.0";"nM";"5.56";"";"";"UO_0000065";"12.24";"0.24";"3.25";"4.54";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL2207215";"";"None";"468.61";"0";"2.34";"20i";"O=C(NCCCNc1nc(Nc2cnn(CCN3CCOCC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.17";"0.32";"5.71";"7.37";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3946038";"";"None";"423.50";"0";"2.39";"BDBM205210";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(CN2CCOCC2)cc1";"IC50";"'='";"645.0";"nM";"6.19";"";"363277";"UO_0000065";"14.62";"0.28";"3.80";"5.61";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891126";"";"None";"459.53";"0";"3.26";"BDBM245938";"N#Cc1cc(-c2ccnc(Nc3ccc(NC4CCNCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429021";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3971959";"";"None";"385.43";"0";"2.85";"BDBM246032";"N#Cc1cc(-c2ccnc(Nc3ccc(C(N)=O)cc3)n2)cnc1N1CCCC1";"IC50";"'<'";"15.0";"nM";"";"";"429115";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947539";"";"None";"444.50";"0";"1.96";"BDBM246045";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)cnc1N1CC[C@H](O)C1";"IC50";"'<'";"30.0";"nM";"";"";"429128";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3956706";"";"None";"537.60";"1";"4.21";"BDBM246050";"CC(NCc1ccccc1)C(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429133";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921294";"";"None";"472.55";"0";"2.61";"BDBM246057";"CC1CN(c2ncc(-c3ccnc(Nc4ccc(CN5CCOCC5)nc4)n3)cc2C#N)CCO1";"IC50";"'<'";"1000.0";"nM";"";"";"429140";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3974819";"";"None";"513.61";"1";"2.47";"BDBM246061";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CCC(CCC(N)=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"429144";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966321";"";"None";"472.55";"0";"2.83";"BDBM246067";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1NCC1CCOC1";"IC50";"'<'";"100.0";"nM";"";"";"429150";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980121";"";"None";"403.45";"0";"1.59";"BDBM246074";"Cn1cc(Nc2nccc(-c3ccc(N4CCC(C(N)=O)CC4)c(C#N)n3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429157";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916744";"";"None";"455.50";"0";"3.65";"BDBM246085";"Cc1nccn1Cc1ccc(Nc2nccc(-c3ccc(N4CC[C@H](F)C4)c(C#N)n3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429168";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919044";"";"None";"472.55";"0";"2.61";"BDBM246088";"N#Cc1nc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)ccc1N1CCCOCC1";"IC50";"'<'";"100.0";"nM";"";"";"429171";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961831";"";"None";"515.58";"2";"2.05";"BDBM246090";"N#Cc1nc(-c2ccnc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)n2)ccc1N1CCCOCC1";"IC50";"'<'";"100.0";"nM";"";"";"429173";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL1230165";"SILMITASERTIB";"2.0";"349.78";"0";"4.88";"25n";"O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"21.32";"0.41";"2.58";"9.93";"1";"CHEMBL1663330";"Inhibition of human recombinant TBK1 by radiometric assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649412";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3687151";"";"None";"457.53";"0";"4.15";"BDBM144185";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"280337";"UO_0000065";"17.70";"0.33";"3.95";"8.75";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687155";"";"None";"401.47";"0";"4.52";"BDBM144189";"N#Cc1cc(-c2ccnc(Nc3cc(C4CC4)n[nH]3)c2)ccc1OC1CCOCC1";"IC50";"'='";"30.0";"nM";"7.52";"";"280341";"UO_0000065";"18.74";"0.34";"3.00";"7.85";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687124";"";"None";"390.45";"0";"3.13";"BDBM144157";"N#Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)ccc1OCC1CCC1";"IC50";"'='";"14.0";"nM";"7.85";"";"280403";"UO_0000065";"20.11";"0.37";"4.72";"7.21";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687125";"";"None";"430.51";"0";"3.76";"BDBM144158";"N#Cc1cc(-c2ccnc(Nc3cnn(C[C@H]4C[C@@H]4CO)c3)n2)ccc1OCC1CCC1";"IC50";"'='";"10.0";"nM";"8.00";"";"280404";"UO_0000065";"18.58";"0.34";"4.24";"7.35";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687130";"";"None";"457.53";"0";"4.61";"BDBM144163";"N#Cc1cc(-c2ccnc(Nc3ccc(C4CCOCC4)nn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"14.0";"nM";"7.85";"";"280409";"UO_0000065";"17.17";"0.32";"3.24";"7.69";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639859";"";"None";"460.54";"0";"3.99";"BDBM144164";"N#Cc1cc(-c2ccnc(Nc3cnn([C@H]4CC[C@H](O)CC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"280410";"UO_0000065";"18.51";"0.34";"4.53";"7.22";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687134";"";"None";"331.38";"0";"3.88";"BDBM144168";"N#Cc1cc(-c2ccnc(Nc3cn[nH]c3)c2)ccc1OCC1CC1";"IC50";"'='";"460.0";"nM";"6.34";"";"280413";"UO_0000065";"19.12";"0.35";"2.46";"7.32";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687180";"";"None";"475.55";"0";"2.85";"BDBM144214";"N#Cc1cc(-c2ccnc(Nc3cnn(CCN4CCOCC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"16.0";"nM";"7.80";"";"280366";"UO_0000065";"16.39";"0.30";"4.95";"7.06";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682434";"";"None";"469.59";"1";"5.13";"BDBM144141";"CN1CCC(c2ccnc(Nc3cc(-c4ccc(OC5CCOCC5)c(C#N)c4)ccn3)c2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"280387";"UO_0000065";"17.68";"0.32";"3.17";"9.97";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687133";"";"None";"471.56";"0";"4.15";"BDBM144167";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"24.0";"nM";"7.62";"";"280427";"UO_0000065";"16.16";"0.30";"3.47";"8.23";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4284443";"";"None";"316.29";"0";"2.88";"109";"CC(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cc1F";"IC50";"'='";"398.11";"nM";"6.40";"";"";"UO_0000065";"20.23";"0.38";"3.52";"6.01";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3426225";"";"None";"576.63";"1";"4.16";"1j";"CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429892";"Inhibition of human TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425429";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3902251";"";"None";"294.32";"0";"1.71";"BDBM209687";"Cn1ccc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)n1";"IC50";"'='";"330.0";"nM";"6.48";"";"370575";"UO_0000065";"22.02";"0.40";"4.77";"6.57";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964958";"";"None";"296.36";"0";"3.04";"BDBM209689";"Nc1ncc(-c2ccsc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"410.0";"nM";"6.39";"";"370576";"UO_0000065";"21.55";"0.42";"3.35";"7.90";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976903";"";"None";"330.35";"0";"2.63";"BDBM209698";"Nc1ncc(-c2cnc3ccccn23)cc1C(=O)Nc1ccncc1";"IC50";"'='";"370.0";"nM";"6.43";"";"370585";"UO_0000065";"19.47";"0.35";"3.80";"6.55";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899325";"";"None";"279.30";"0";"2.31";"BDBM209699";"Nc1ncc(-c2cc[nH]c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"150.0";"nM";"6.82";"";"370586";"UO_0000065";"24.43";"0.44";"4.51";"7.06";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967101";"";"None";"498.59";"0";"2.55";"BDBM245940";"CN1CCC(NC(=O)c2cccc(Nc3nccc(-c4cnc(N5CC[C@H](O)C5)c(C#N)c4)n3)c2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"429023";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906502";"";"None";"492.53";"0";"3.52";"BDBM245973";"N#Cc1cc(-c2ccnc(Nc3ccc(OCCN4CC[C@H](F)C4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429056";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892095";"";"None";"517.57";"1";"2.39";"BDBM245977";"CN(C(=O)CN1CCOCC1)c1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429060";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895616";"";"None";"490.54";"0";"2.75";"BDBM245990";"N#Cc1cc(-c2nc(Nc3ccc(CN4CCOCC4)nc3)ncc2F)cnc1N1CCCOCC1";"IC50";"'<'";"100.0";"nM";"";"";"429073";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3909236";"";"None";"484.56";"0";"2.61";"BDBM245995";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CCC2(COC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"429078";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3984412";"";"None";"527.59";"2";"2.05";"BDBM245996";"N#Cc1cc(-c2ccnc(Nc3ccnc(NC(=O)CN4CCOCC4)c3)n2)cnc1N1CCC2(COC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"429079";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976096";"";"None";"460.52";"0";"2.93";"BDBM246002";"N#Cc1cc(-c2ccnc(Nc3ccnc(CN4CCOCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429085";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3928858";"";"None";"434.48";"0";"2.53";"BDBM246004";"CN(CCO)c1cc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)ccn1";"IC50";"'<'";"30.0";"nM";"";"";"429087";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943961";"";"None";"418.48";"0";"3.29";"BDBM246011";"CC(C)(N)c1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429094";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929670";"";"None";"460.52";"0";"2.66";"BDBM246014";"CC1(O)CN(Cc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)C1";"IC50";"'<'";"100.0";"nM";"";"";"429097";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114133";"";"None";"503.54";"1";"2.37";"BDBM246015";"N#Cc1cc(-c2ccnc(Nc3ccnc(NC(=O)CN4CCOCC4)c3)n2)cnc1N1CC[C@@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429098";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109686";"";"None";"503.54";"1";"2.37";"BDBM246016";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)n2)cnc1N1CC[C@@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429099";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3913460";"";"None";"515.44";"1";"3.07";"BDBM205192";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4Br)nc3C(N)=O)cc2)CC1";"IC50";"'='";"310.0";"nM";"6.51";"";"363259";"UO_0000065";"12.63";"0.28";"3.44";"6.23";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3937277";"";"None";"509.59";"1";"3.01";"BDBM205213";"CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cn2)CC1";"IC50";"'='";"1200.0";"nM";"5.92";"";"363280";"UO_0000065";"11.62";"0.22";"2.91";"4.12";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2207220";"";"None";"512.31";"2";"5.37";"10c";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)c1ccc(C(F)(F)F)cc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"12.39";"0.27";"0.98";"8.04";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207211";"";"None";"395.51";"0";"3.35";"20e";"O=C(NCCCNc1nc(Nc2cnn(C3CC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"20.23";"0.38";"4.65";"8.27";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207196";"";"None";"422.58";"0";"3.88";"17b";"CN(C)Cc1ccc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"19.46";"0.36";"4.34";"10.00";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3984327";"";"None";"401.45";"0";"3.31";"BDBM246029";"N#Cc1cc(-c2ccnc(Nc3ccc4c(c3)CNC4)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429112";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3889505";"";"None";"473.54";"0";"1.69";"BDBM246064";"CC(C(N)=O)N(C)c1ncc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cc1C#N";"IC50";"'<'";"100.0";"nM";"";"";"429147";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943539";"";"None";"486.58";"0";"2.85";"BDBM246066";"CN(CC1CCOC1)c1ncc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cc1C#N";"IC50";"'<'";"1000.0";"nM";"";"";"429149";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3650711";"";"None";"345.41";"0";"3.09";"BDBM148095";"Cn1nccc1Nc1nccc(-c2ccc(N3CCCC3)c(C#N)c2)n1";"IC50";"'<'";"30.0";"nM";"";"";"286081";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3945627";"";"None";"446.49";"0";"3.09";"BDBM246026";"N#Cc1cc(-c2nc(Nc3ccc(CN4CCOCC4)nc3)ncc2F)cnc1NC1CC1";"IC50";"'<'";"100.0";"nM";"";"";"429109";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112421";"";"None";"469.51";"1";"2.23";"BDBM246036";"Cn1cc(NC(=O)[C@H]2CCCN2c2ncc(-c3ccnc(Nc4cnn(C)c4)n3)cc2C#N)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429119";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3942227";"";"None";"408.44";"0";"2.28";"BDBM246047";"N#Cc1cc(-c2ccnc(Nc3cnn(CCCO)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429130";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3984323";"";"None";"499.58";"0";"2.08";"BDBM246056";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CCC(CC(N)=O)C1";"IC50";"'<'";"100.0";"nM";"";"";"429139";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916574";"";"None";"459.51";"0";"1.67";"BDBM246063";"CC(Nc1ncc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cc1C#N)C(N)=O";"IC50";"'<'";"100.0";"nM";"";"";"429146";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3977034";"";"None";"448.51";"0";"2.83";"BDBM246095";"COCCNCc1ccc(Nc2nccc(-c3ccc(N4CC[C@H](F)C4)c(C#N)n3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429178";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2207181";"";"None";"422.30";"0";"3.84";"10h";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)C1CCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"20.60";"0.46";"4.86";"11.02";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3915353";"";"None";"369.41";"0";"1.63";"BDBM209644";"Nc1ncc(-c2ccc(S(N)(=O)=O)cc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"150.0";"nM";"6.82";"";"370537";"UO_0000065";"18.47";"0.36";"5.19";"4.84";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899705";"";"None";"439.54";"0";"3.27";"BDBM209646";"CCOc1cc(NC(=O)c2cc(-c3ccc(CN4CCOCC4)s3)cnc2N)ccn1";"IC50";"'='";"430.0";"nM";"6.37";"";"370539";"UO_0000065";"14.48";"0.28";"3.10";"6.21";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3898836";"";"None";"280.29";"0";"2.57";"BDBM209685";"Nc1ncc(-c2ccoc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"610.0";"nM";"6.21";"";"370573";"UO_0000065";"22.17";"0.40";"3.64";"6.61";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4515413";"";"None";"509.54";"1";"4.67";"26";"Cc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ccn1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"14.26";"0.27";"2.60";"8.07";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3650726";"";"None";"481.60";"0";"4.18";"BDBM148110";"CN1CCC(NC(=O)c2cccc(Nc3nccc(-c4ccc(N5CCCC5)c(C#N)c4)n3)c2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286091";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3937942";"";"None";"338.37";"0";"1.82";"BDBM209643";"COCCn1cc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)cn1";"IC50";"'='";"67.0";"nM";"7.17";"";"370536";"UO_0000065";"21.20";"0.39";"5.35";"6.65";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3981212";"";"None";"380.45";"0";"4.95";"BDBM209663";"Cc1ccc(-c2cccc(-c3cnc(N)c(C(=O)Nc4ccncc4)c3)c2)cc1";"IC50";"'='";"7400.0";"nM";"5.13";"";"370553";"UO_0000065";"13.49";"0.24";"0.18";"6.34";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894537";"";"None";"293.33";"0";"2.32";"BDBM209690";"Cn1cccc1-c1cnc(N)c(C(=O)Nc2ccncc2)c1";"IC50";"'='";"320.0";"nM";"6.50";"";"370577";"UO_0000065";"22.14";"0.40";"4.17";"7.57";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3939553";"";"None";"393.45";"0";"1.51";"BDBM209691";"Nc1ncc(-c2cnn(CCN3CCOCC3)c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"740.0";"nM";"6.13";"";"370578";"UO_0000065";"15.58";"0.29";"4.62";"5.51";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3982817";"";"None";"395.49";"0";"2.87";"BDBM209694";"Nc1ncc(-c2ccc(CN3CCOCC3)s2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"88.0";"nM";"7.06";"";"370581";"UO_0000065";"17.84";"0.34";"4.19";"7.56";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925601";"";"None";"294.32";"0";"1.71";"BDBM209701";"Cn1cc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)cn1";"IC50";"'='";"160.0";"nM";"6.80";"";"370588";"UO_0000065";"23.09";"0.42";"5.09";"6.88";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961973";"";"None";"393.52";"0";"4.03";"BDBM209702";"Nc1ncc(-c2ccc(CN3CCCCC3)s2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"370640";"UO_0000065";"15.14";"0.29";"1.93";"7.08";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926136";"";"None";"454.53";"0";"2.44";"BDBM205173";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccnc(F)c4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"630.0";"nM";"6.20";"";"363253";"UO_0000065";"13.64";"0.26";"3.76";"5.94";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3983696";"";"None";"437.53";"0";"3.02";"BDBM205206";"CNC(=O)CCCCc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"363273";"UO_0000065";"15.13";"0.29";"3.60";"5.21";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3972661";"";"None";"330.39";"0";"2.62";"BDBM205236";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1cccs1";"IC50";"'='";"2000.0";"nM";"5.70";"";"363294";"UO_0000065";"17.25";"0.35";"3.08";"5.82";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3946536";"";"None";"314.33";"0";"1.28";"BDBM205237";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1cc[nH]n1";"IC50";"'='";"2700.0";"nM";"5.57";"";"363295";"UO_0000065";"17.72";"0.35";"4.29";"4.40";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"2.18";"nM";"8.66";"";"";"UO_0000065";"18.57";"0.34";"4.31";"12.47";"0";"CHEMBL4328628";"Inhibition of human TBK1 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3650722";"";"None";"388.44";"0";"2.19";"BDBM148106";"Cn1nc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cc1C(N)=O";"IC50";"'<'";"3000.0";"nM";"";"";"286087";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4538751";"";"None";"524.55";"1";"4.62";"29";"Cc1cc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.58";"0.31";"4.08";"8.45";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4543618";"";"None";"568.60";"2";"5.10";"35";"CC(C)Oc1cncnc1-c1ccc2nc(Nc3cc([C@@H](C)N4CCN(C(=O)CC(F)(F)F)CC4)ccn3)[nH]c2c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"12.84";"0.24";"2.20";"6.51";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL2011912";"";"None";"319.17";"0";"2.41";"2j";"CNc1c(Br)cnc2[nH]c(-c3ccnc(N)c3)nc12";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"22.03";"0.51";"4.62";"7.60";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011926";"";"None";"416.32";"0";"3.81";"4a";"COc1ccc(-c2nc3c(NCC4CCNCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"17.40";"0.38";"3.43";"9.68";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011927";"";"None";"417.31";"0";"3.77";"4b";"COc1ccc(-c2nc3c(OCC4CCNCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"17.75";"0.39";"3.64";"10.28";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011938";"";"None";"481.35";"0";"4.02";"4m";"COc1ccc(-c2nc3c(NCCCNC(=O)c4cccnc4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"15.02";"0.32";"3.21";"6.90";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011939";"";"None";"486.40";"0";"4.69";"4n";"COc1ccc(-c2nc3c(NCCCNC(=O)c4cccs4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"15.08";"0.33";"2.65";"7.98";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011940";"";"None";"443.35";"0";"3.69";"4o";"Nc1cccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.22";"0.42";"4.83";"7.84";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011942";"";"None";"519.65";"1";"3.31";"5a";"NC(=O)c1cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1NCCCNC(=O)C1CCC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.16";"0.30";"5.09";"6.07";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL1096";"AMLEXANOX";"4.0";"298.30";"0";"2.75";"5";"CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"20.35";"0.38";"3.32";"5.70";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4285560";"";"None";"298.30";"0";"2.75";"106";"CC(C)c1ccc2c(=O)c3cc(C(=O)O)c(N)nc3oc2c1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"21.87";"0.40";"3.77";"6.13";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4285588";"";"None";"396.40";"0";"3.02";"141";"Nc1nc2oc3ccc(C4CCC5(CC4)OCCO5)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"16.04";"0.30";"3.34";"5.09";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4279336";"";"None";"338.32";"0";"2.43";"148";"Nc1nc2oc3ccc(C4=CCOCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"860.0";"nM";"6.07";"";"";"UO_0000065";"17.93";"0.33";"3.64";"5.24";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL2207208";"";"None";"369.47";"0";"2.55";"20b";"Cn1cc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cn1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"21.91";"0.41";"5.55";"8.37";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207205";"";"None";"419.53";"0";"3.70";"19b";"Cn1ncc2cc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)ccc21";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"18.58";"0.34";"4.10";"8.06";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207189";"";"None";"411.51";"0";"4.53";"15b";"O=C(NCCCNc1nc(Nc2ccccc2F)ncc1C1CC1)c1cccs1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"14.79";"0.29";"1.56";"7.71";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3650703";"";"None";"398.47";"0";"3.77";"BDBM148087";"Cc1cc(C(N)=O)ccc1Nc1nccc(-c2ccc(N3CCCC3)c(C#N)c2)n1";"IC50";"'<'";"300.0";"nM";"";"";"286074";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687167";"";"None";"416.49";"0";"3.26";"BDBM144201";"N#Cc1cc(-c2ccnc(Nc3cnn(C4CNC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"290.0";"nM";"6.54";"";"280353";"UO_0000065";"15.70";"0.29";"3.28";"6.74";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682432";"";"None";"484.56";"0";"4.10";"BDBM144139";"COc1nc(Nc2nccc(-c3ccc(OC4CCOCC4)c(C#N)c3)n2)ccc1C1=CCNCC1";"IC50";"'='";"27.0";"nM";"7.57";"";"280385";"UO_0000065";"15.62";"0.29";"3.47";"6.63";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2207202";"";"None";"463.63";"0";"4.20";"18c";"O=C(NCCCNc1nc(Nc2ccc(CN3CCCCC3)nc2)ncc1C1CC1)C1CCC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.35";"0.32";"3.85";"8.46";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207214";"";"None";"439.56";"0";"3.36";"20h";"O=C(NCCCNc1nc(Nc2cnn(C3CCOCC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.79";"0.37";"5.34";"8.21";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3900950";"";"None";"310.38";"0";"3.35";"BDBM209640";"Cc1ccc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)s1";"IC50";"'='";"120.0";"nM";"6.92";"";"370533";"UO_0000065";"22.30";"0.43";"3.57";"8.55";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2207212";"";"None";"409.54";"0";"3.74";"20f";"O=C(NCCCNc1nc(Nc2cnn(C3CCC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.24";"0.40";"4.96";"8.99";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3682423";"";"None";"446.51";"0";"3.14";"BDBM144130";"N#Cc1cc(-c2ccnc(Nc3cnn(C[C@H]4C[C@@H]4CO)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"280376";"UO_0000065";"18.41";"0.34";"5.08";"6.96";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650748";"";"None";"415.46";"0";"2.68";"BDBM148132";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CC[C@@H](O)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286113";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3891661";"";"None";"380.48";"0";"3.03";"BDBM209653";"Nc1ncc(-c2ccc(CN3CCCC3)s2)nc1C(=O)Nc1ccncc1";"IC50";"'='";"4200.0";"nM";"5.38";"";"370544";"UO_0000065";"14.13";"0.27";"2.35";"5.54";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3928914";"";"None";"356.39";"0";"3.16";"BDBM209641";"Nc1ncc(-c2cccc(-n3cccn3)c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"4500.0";"nM";"5.35";"";"370641";"UO_0000065";"15.00";"0.27";"2.19";"5.42";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906387";"";"None";"356.39";"0";"3.16";"BDBM209642";"Nc1ncc(-c2ccc(-n3cccn3)cc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"370642";"UO_0000065";"14.03";"0.25";"1.84";"5.06";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2207210";"";"None";"383.50";"0";"3.03";"20d";"CCn1cc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"21.26";"0.40";"5.12";"8.43";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207207";"";"None";"369.47";"0";"2.55";"20a";"Cn1ccc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)n1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207200";"";"None";"366.47";"0";"3.21";"18a";"O=C(NCCCNc1nc(Nc2cccnc2)ncc1C1CC1)C1CCC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"21.52";"0.40";"4.68";"8.59";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207198";"";"None";"450.59";"0";"3.65";"17d";"O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C1CC1)C1CCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"18.25";"0.34";"4.57";"8.99";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207188";"";"None";"411.51";"0";"4.53";"15a";"O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1C1CC1)c1cccs1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"16.91";"0.33";"2.43";"8.82";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3650736";"";"None";"483.58";"0";"2.36";"BDBM148120";"CN1CCN(c2ccc(Nc3nccc(-c4ccc(N5CCC[C@@H]5C(N)=O)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286101";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650755";"";"None";"490.56";"0";"4.51";"BDBM148139";"CN1CCC(Nc2ccc(Nc3nccc(-c4ccc(N5CCC(F)(F)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286120";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1096";"AMLEXANOX";"4.0";"298.30";"0";"2.75";"5";"CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"851.14";"nM";"6.07";"";"";"UO_0000065";"20.35";"0.38";"3.32";"5.70";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3900659";"";"None";"334.34";"0";"2.68";"BDBM209677";"Nc1ncc(-c2cccc(C(=O)O)c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"370567";"UO_0000065";"17.82";"0.33";"3.28";"5.04";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925987";"";"None";"329.36";"0";"3.46";"BDBM209695";"Nc1ncc(-c2cc3ccccc3[nH]2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"390.0";"nM";"6.41";"";"370582";"UO_0000065";"19.46";"0.35";"2.95";"6.63";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961973";"";"None";"393.52";"0";"4.03";"BDBM209702";"Nc1ncc(-c2ccc(CN3CCCCC3)s2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"390.0";"nM";"6.41";"";"370531";"UO_0000065";"16.29";"0.31";"2.38";"7.62";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904581";"";"None";"471.57";"0";"3.26";"BDBM246018";"CN1CCC(Nc2ccc(Nc3nccc(-c4cnc(NC5CCOC5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"429101";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3973089";"";"None";"513.61";"1";"2.49";"BDBM246054";"CC(=O)NCC1CCCN1c1ncc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cc1C#N";"IC50";"'<'";"1000.0";"nM";"";"";"429137";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3889803";"";"None";"499.55";"0";"3.19";"BDBM246083";"C[C@H]1COCCN1Cc1ccc(Nc2nccc(-c3cc(C#N)c(N4CC[C@H](F)C4)c(C#N)n3)n2)cn1";"IC50";"'<'";"15.0";"nM";"";"";"429166";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3946601";"";"None";"401.47";"0";"3.06";"BDBM246092";"CN(C)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc1C#N";"IC50";"'<'";"15.0";"nM";"";"";"429175";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4287847";"";"None";"299.29";"0";"2.14";"111";"CC(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cn1";"IC50";"'='";"85113.8";"nM";"4.07";"";"";"UO_0000065";"13.60";"0.25";"1.93";"3.41";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4436188";"";"None";"566.63";"2";"5.52";"25";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cnn(CC5CCC5)c4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.35";"0.29";"3.18";"9.16";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4438389";"";"None";"472.48";"0";"3.74";"10";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"188.0";"nM";"6.73";"";"";"UO_0000065";"14.24";"0.27";"2.99";"6.79";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4545291";"";"None";"490.57";"0";"4.11";"4";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)OC(C)(C)C)CC5)ccn4)[nH]c3c2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL1738710";"";"None";"449.84";"0";"2.77";"10";"Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1798625";"Inhibition of TBK1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1795201";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3910247";"";"None";"423.54";"0";"3.49";"BDBM209666";"Cc1cc(NC(=O)c2cc(-c3ccc(CN4CCOCC4)s3)cnc2N)cc(C)n1";"IC50";"'='";"8200.0";"nM";"5.09";"";"370556";"UO_0000065";"12.01";"0.23";"1.60";"5.45";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959788";"";"None";"452.54";"0";"2.83";"BDBM209676";"CC(=O)Nc1cc(NC(=O)c2cc(-c3ccc(CN4CCOCC4)s3)cnc2N)ccn1";"IC50";"'='";"190.0";"nM";"6.72";"";"370566";"UO_0000065";"14.85";"0.29";"3.89";"5.49";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3897770";"";"None";"324.34";"0";"1.17";"BDBM209682";"Nc1ncc(-c2cnn(CCO)c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"670.0";"nM";"6.17";"";"370570";"UO_0000065";"19.04";"0.35";"5.00";"5.19";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943325";"";"None";"409.52";"0";"3.18";"BDBM209645";"Cc1cc(NC(=O)c2cc(-c3ccc(CN4CCOCC4)s3)cnc2N)ccn1";"IC50";"'='";"3100.0";"nM";"5.51";"";"370644";"UO_0000065";"13.45";"0.26";"2.33";"5.90";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3938167";"";"None";"396.48";"0";"2.27";"BDBM209667";"Nc1ncc(-c2ccc(CN3CCOCC3)s2)cc1C(=O)Nc1ccncn1";"IC50";"'='";"810.0";"nM";"6.09";"";"370557";"UO_0000065";"15.36";"0.30";"3.82";"5.73";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4454902";"";"None";"580.62";"2";"5.10";"31";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(OCC5CC5)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.98";"0.28";"3.60";"7.76";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4462056";"";"None";"484.52";"0";"3.61";"14";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)c6ccco6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"429.0";"nM";"6.37";"";"";"UO_0000065";"13.14";"0.24";"2.76";"4.93";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4461416";"";"None";"432.53";"0";"3.59";"6";"CCCN1CCN(Cc2ccnc(Nc3nc4ccc(-c5nc(C)no5)cc4[nH]3)c2)CC1";"IC50";"'='";"1440.0";"nM";"5.84";"";"";"UO_0000065";"13.51";"0.25";"2.25";"5.90";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4483062";"";"None";"472.55";"0";"3.50";"12";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC6CC6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"1920.0";"nM";"5.72";"";"";"UO_0000065";"12.10";"0.22";"2.22";"4.93";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4552254";"";"None";"510.52";"1";"4.06";"28";"Cc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"434.0";"nM";"6.36";"";"";"UO_0000065";"12.46";"0.23";"2.30";"6.18";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4594167";"";"None";"525.54";"1";"3.80";"32";"CNc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"12.96";"0.24";"3.01";"5.92";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4290544";"";"None";"312.33";"0";"2.82";"116";"CC(C)Cc1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"20.04";"0.37";"3.44";"5.88";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4532014";"";"None";"541.66";"1";"4.40";"AZ13102909";"COc1ccc(-c2ccc(-c3nc4c(NNCCCNC(=O)C5CCCCC5)c(C(N)=O)cnc4[nH]3)cc2)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.33";"0.28";"3.90";"5.65";"0";"CHEMBL4373769";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL4550702";"";"None";"406.39";"0";"3.15";"9";"Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4479785";"Inhibition of full-length recombinant human GST-tagged TBK1 expressed in insect cells by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL577784";"BX-795";"None";"591.48";"1";"4.75";"BX-795";"O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.69";"0.33";"3.35";"7.28";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4088216";"TP-030-1";"None";"402.45";"0";"2.35";"EUB0000719";"CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4884876";"TBK1(TBK1CGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM";""
"CHEMBL4446892";"";"None";"520.34";"1";"3.31";"GSK8612";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"501.19";"nM";"6.30";"";"";"UO_0000065";"12.11";"0.28";"2.99";"4.93";"0";"CHEMBL4364418";"Inhibition of TBK1 in human THP1 cells assessed as decrease in c-GAMP stimulated IFNbeta secretion preincubated for 45 mins followed by c-GAMP addition and measured after 20 hrs by electrochemiluminescence method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364239";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";""
"CHEMBL4078893";"";"None";"427.81";"0";"4.43";"7";"FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4007750";"Inhibition of TBK1 (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL2011901";"";"None";"376.46";"0";"3.40";"1g";"CNc1c(C#N)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12";"IC50";"'='";"426.0";"nM";"6.37";"";"";"UO_0000065";"16.92";"0.31";"2.97";"7.09";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011902";"";"None";"435.75";"0";"4.91";"1h";"Clc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12";"IC50";"'='";"2740.0";"nM";"5.56";"";"";"UO_0000065";"12.76";"0.29";"0.65";"10.29";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011910";"";"None";"318.18";"0";"3.01";"2h";"CNc1c(Br)cnc2[nH]c(-c3cccc(N)c3)nc12";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"22.59";"0.52";"4.18";"9.03";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011918";"";"None";"445.37";"0";"3.06";"2p";"CNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCN(C)CC4)cc3)nc12";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"15.66";"0.34";"3.91";"10.06";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011930";"";"None";"460.38";"0";"4.36";"4e";"COc1ccc(-c2nc3c(NCCCNC(=O)C(C)(C)C)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"17.71";"0.38";"3.79";"8.87";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011935";"";"None";"474.36";"0";"3.09";"4j";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CC(O)C4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.07";"0.37";"5.01";"7.22";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011937";"";"None";"480.37";"0";"4.63";"4l";"COc1ccc(-c2nc3c(NCCCNC(=O)c4ccccc4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"14.52";"0.31";"2.34";"7.59";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3650752";"";"None";"472.57";"0";"4.21";"BDBM148136";"CN1CCC(Nc2ccc(Nc3nccc(-c4ccc(N5CC[C@@H](F)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286117";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125723";"";"None";"452.58";"0";"3.38";"23";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(C(N)=S)cnc3[nH]2)cc1";"IC50";"'='";"165.0";"nM";"6.78";"";"";"UO_0000065";"14.99";"0.29";"3.40";"5.75";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125720";"";"None";"575.74";"2";"5.25";"26";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)NCC(C)C)cs4)cnc3[nH]2)cc1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"11.97";"0.23";"1.64";"5.15";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125733";"";"None";"364.43";"0";"3.72";"13";"CNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1";"IC50";"'='";"851.0";"nM";"6.07";"";"";"UO_0000065";"16.66";"0.32";"2.35";"7.60";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125731";"";"None";"408.48";"0";"3.74";"15";"COCCNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"17.16";"0.33";"3.27";"7.86";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4438748";"";"None";"457.49";"0";"4.13";"12j";"CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379458";"Inhibition of recombinant full length human TBK1 using KRRRALS(p)VAS as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376834";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL4453481";"";"None";"512.54";"1";"4.18";"22";"CCn1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)cn1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"14.24";"0.27";"3.12";"7.69";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4455930";"";"None";"514.51";"1";"4.22";"15";"Cc1noc(-c2ccc3nc(Nc4cc(C(C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"14.52";"0.28";"3.25";"6.43";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4587843";"";"None";"454.49";"0";"3.44";"9";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CC(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"2040.0";"nM";"5.69";"";"";"UO_0000065";"12.52";"0.24";"2.25";"5.75";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4466150";"";"None";"526.52";"1";"4.23";"19";"O=C(CC(F)(F)F)N1CCN(Cc2ccnc(Nc3nc4ccc(-c5nc(C6CC6)no5)cc4[nH]3)c2)CC1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4277195";"";"None";"297.27";"0";"2.05";"112";"C=C(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cn1";"IC50";"'='";"524807.46";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4594167";"";"None";"525.54";"1";"3.80";"32";"CNc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.22";"0.29";"4.20";"6.96";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4547610";"";"None";"542.57";"1";"4.55";"20";"CC(C)Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"13.16";"0.25";"2.59";"6.15";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4461416";"";"None";"432.53";"0";"3.59";"6";"CCCN1CCN(Cc2ccnc(Nc3nc4ccc(-c5nc(C)no5)cc4[nH]3)c2)CC1";"IC50";"'='";"16700.0";"nM";"4.78";"";"";"UO_0000065";"11.04";"0.20";"1.19";"4.83";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4456062";"";"None";"515.54";"1";"3.44";"2";"O=C(NCC1CC1)c1ccc2nc(Nc3cc(CN4CCN(C(=O)CC(F)(F)F)CC4)ccn3)[nH]c2c1";"IC50";"'='";"1390.0";"nM";"5.86";"";"";"UO_0000065";"11.36";"0.22";"2.42";"5.51";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4538591";"BAY-440";"None";"574.01";"1";"4.47";"36; BAY-440";"CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl";"IC50";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"10.35";"0.20";"1.47";"5.60";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL577784";"BX-795";"None";"591.48";"1";"4.75";"BX-795";"O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"12.42";"0.30";"2.60";"6.60";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4435393";"";"None";"552.61";"2";"5.13";"24";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cnn(CC5CC5)c4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"16.29";"0.31";"3.87";"9.48";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4466150";"";"None";"526.52";"1";"4.23";"19";"O=C(CC(F)(F)F)N1CCN(Cc2ccnc(Nc3nc4ccc(-c5nc(C6CC6)no5)cc4[nH]3)c2)CC1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"13.74";"0.26";"3.01";"6.23";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4483062";"";"None";"472.55";"0";"3.50";"12";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC6CC6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"14.68";"0.27";"3.44";"5.98";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4438389";"";"None";"472.48";"0";"3.74";"10";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"3740.0";"nM";"5.43";"";"";"UO_0000065";"11.49";"0.22";"1.69";"5.48";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4435393";"";"None";"552.61";"2";"5.13";"24";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cnn(CC5CC5)c4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.01";"0.26";"2.61";"8.15";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3650704";"";"None";"345.41";"0";"3.09";"BDBM148088";"Cn1cc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286075";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4468020";"";"None";"538.58";"1";"4.57";"23";"O=C(CC(F)(F)F)N1CCN(Cc2ccnc(Nc3nc4ccc(-c5cnn(CC6CC6)c5)cc4[nH]3)c2)CC1";"IC50";"'='";"137.0";"nM";"6.86";"";"";"UO_0000065";"12.74";"0.24";"2.29";"7.23";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4569508";"";"None";"529.59";"2";"5.28";"1";"O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4479785";"Inhibition of full-length recombinant human GST-tagged TBK1 expressed in insect cells by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3911737";"";"None";"499.58";"0";"2.10";"BDBM246058";"CC(=O)NC1CCN(c2ncc(-c3ccnc(Nc4ccc(CN5CCOCC5)nc4)n3)cc2C#N)C1";"IC50";"'<'";"1000.0";"nM";"";"";"429141";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955989";"";"None";"518.57";"1";"3.82";"BDBM245942";"CN1CCC(NC(=O)c2cccc(Nc3nccc(-c4cnc(N5CCC(F)(F)C5)c(C#N)c4)n3)c2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"429025";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929435";"";"None";"447.48";"0";"2.33";"BDBM245948";"N#Cc1cc(-c2ccnc(Nc3cnc(N4CCOCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429031";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4462056";"";"None";"484.52";"0";"3.61";"14";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)c6ccco6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"5070.0";"nM";"5.29";"";"";"UO_0000065";"10.93";"0.20";"1.68";"4.10";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3931115";"";"None";"500.58";"1";"3.53";"BDBM245929";"CN1CCC(NC(=O)c2cccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)c2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"429012";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941967";"";"None";"475.53";"0";"2.99";"BDBM245946";"CC(C(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1)N(C)C";"IC50";"'<'";"100.0";"nM";"";"";"429029";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940846";"";"None";"460.52";"0";"2.93";"BDBM245986";"COC1CN(Cc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)C1";"IC50";"'<'";"30.0";"nM";"";"";"429069";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927596";"";"None";"515.58";"2";"2.05";"BDBM245988";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)n2)cnc1N1CCCOCC1";"IC50";"'<'";"100.0";"nM";"";"";"429071";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968958";"";"None";"458.53";"0";"1.95";"BDBM246078";"N#Cc1nc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)ccc1N1CC[C@H](O)C1";"IC50";"'<'";"30.0";"nM";"";"";"429161";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975183";"";"None";"370.42";"0";"3.22";"BDBM209686";"Nc1ncc(-c2cnn(Cc3ccccc3)c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"120.0";"nM";"6.92";"";"370574";"UO_0000065";"18.68";"0.34";"3.70";"7.01";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3958551";"";"None";"346.42";"0";"4.19";"BDBM209692";"Nc1ncc(-c2cc3ccccc3s2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"630.0";"nM";"6.20";"";"370579";"UO_0000065";"17.90";"0.34";"2.01";"7.66";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953224";"";"None";"330.35";"0";"3.72";"BDBM209700";"Nc1ncc(-c2coc3ccccc23)cc1C(=O)Nc1ccncc1";"IC50";"'='";"230.0";"nM";"6.64";"";"370587";"UO_0000065";"20.09";"0.36";"2.92";"7.06";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125727";"";"None";"406.51";"0";"4.75";"19";"COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"17.50";"0.34";"2.36";"8.90";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3650690";"";"None";"398.47";"0";"4.32";"BDBM148073";"CC(=O)Nc1cccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)c1";"IC50";"'<'";"30.0";"nM";"";"";"286064";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687176";"";"None";"420.47";"0";"3.16";"BDBM144210";"COCCn1cc(Nc2nccc(-c3ccc(OC4CCOCC4)c(C#N)c3)n2)cn1";"IC50";"'='";"6.0";"nM";"8.22";"";"280362";"UO_0000065";"19.55";"0.36";"5.06";"7.68";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687182";"";"None";"446.51";"0";"3.55";"BDBM144216";"N#Cc1cc(-c2ccnc(Nc3cnn(CC4CCOC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"12.0";"nM";"7.92";"";"280368";"UO_0000065";"17.74";"0.33";"4.37";"7.40";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687131";"";"None";"403.44";"0";"3.20";"BDBM144165";"N#Cc1cc(-c2ccnc(Nc3nccnc3CO)c2)ccc1OC1CCOCC1";"IC50";"'='";"350.0";"nM";"6.46";"";"280411";"UO_0000065";"16.00";"0.29";"3.26";"5.70";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687172";"";"None";"529.65";"1";"3.71";"BDBM144206";"N#Cc1cc(-c2ccnc(Nc3cnn(CCC4CCN(C(=O)CN)CC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"42.0";"nM";"7.38";"";"280358";"UO_0000065";"13.93";"0.26";"3.67";"5.62";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4287123";"";"None";"322.32";"0";"2.63";"118";"CC(C)C#Cc1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"50118723.36";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4281345";"";"None";"323.32";"0";"1.17";"170";"CN(C)c1ccc2oc3nc(N)c(-c4nn[nH]n4)cc3c(=O)c2c1";"IC50";"'='";"524.81";"nM";"6.28";"";"";"UO_0000065";"19.42";"0.36";"5.11";"4.95";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4288542";"";"None";"365.35";"0";"0.94";"171";"Nc1nc2oc3ccc(N4CCOCC4)cc3c(=O)c2cc1-c1nn[nH]n1";"IC50";"'='";"537.03";"nM";"6.27";"";"";"UO_0000065";"17.16";"0.32";"5.33";"4.61";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3125724";"";"None";"520.61";"2";"5.14";"22";"COc1ccc(-c2nc3c(OCCCNC(=O)C4CCCC4)c(-c4csc(C(=O)O)c4)cnc3[nH]2)cc1";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3650706";"";"None";"372.43";"0";"3.76";"BDBM148090";"COc1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286077";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3604928";"";"None";"410.44";"0";"2.70";"Tozasertib-15a";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc([N+](=O)[O-])cc3)n2)n[nH]1";"IC50";"'='";"0.06";"nM";"10.22";"";"";"UO_0000065";"24.90";"0.47";"7.52";"8.16";"0";"CHEMBL4373750";"Inhibition of TBK1 (unknown origin) using biotinylated peptide as substrate preincubated for 30 mins by fluorescence activity-based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL3650699";"";"None";"410.48";"0";"4.24";"BDBM148083";"N#Cc1cc(-c2ccnc(Nc3ccc4c(c3)NC(=O)CC4)n2)ccc1N1CCCC1";"IC50";"'<'";"30.0";"nM";"";"";"286071";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4552254";"";"None";"510.52";"1";"4.06";"28";"Cc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"15.33";"0.29";"3.76";"7.60";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4566710";"";"None";"486.50";"0";"4.13";"8";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(CCC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"5290.0";"nM";"5.28";"";"";"UO_0000065";"10.85";"0.21";"1.15";"5.33";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4455930";"";"None";"514.51";"1";"4.22";"15";"Cc1noc(-c2ccc3nc(Nc4cc(C(C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"829.0";"nM";"6.08";"";"";"UO_0000065";"11.82";"0.22";"1.86";"5.24";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4577511";"";"None";"514.51";"1";"4.22";"16";"Cc1noc(-c2ccc3nc(Nc4cc([C@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"2490.0";"nM";"5.60";"";"";"UO_0000065";"10.89";"0.21";"1.38";"4.83";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4515413";"";"None";"509.54";"1";"4.67";"26";"Cc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ccn1";"IC50";"'='";"391.0";"nM";"6.41";"";"";"UO_0000065";"12.58";"0.24";"1.74";"7.12";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3956191";"";"None";"461.55";"0";"2.18";"BDBM205176";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccnc(C#N)c4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"2000.0";"nM";"5.70";"";"363256";"UO_0000065";"12.35";"0.24";"3.52";"4.44";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950168";"";"None";"466.57";"0";"2.31";"BDBM205195";"COc1cnccc1-c1nc(C(N)=O)c(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)s1";"IC50";"'='";"46.0";"nM";"7.34";"";"363262";"UO_0000065";"15.73";"0.30";"5.03";"6.45";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3958876";"";"None";"464.55";"0";"2.89";"BDBM205197";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(CC2CCN(C(N)=O)CC2)cc1";"IC50";"'='";"94.0";"nM";"7.03";"";"363264";"UO_0000065";"15.13";"0.29";"4.14";"4.87";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3981105";"";"None";"421.53";"0";"3.10";"BDBM205203";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(CC2CCNCC2)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"363270";"UO_0000065";"15.94";"0.31";"3.62";"6.11";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3650749";"";"None";"361.41";"0";"2.06";"BDBM148133";"Cn1cc(Nc2nccc(-c3ccc(N4CC[C@H](O)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286114";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650738";"";"None";"442.57";"0";"4.12";"BDBM148122";"C[C@H]1CCCN1c1ccc(-c2ccnc(Nc3ccc(NCCN(C)C)nc3)n2)cc1C#N";"IC50";"'<'";"30.0";"nM";"";"";"286103";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3923200";"";"None";"280.29";"0";"1.70";"BDBM209674";"Nc1ncc(-c2cn[nH]c2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"280.0";"nM";"6.55";"";"370564";"UO_0000065";"23.38";"0.43";"4.85";"5.98";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895236";"";"None";"453.52";"0";"2.66";"BDBM209675";"COC(=O)c1cnccc1NC(=O)c1cc(-c2ccc(CN3CCOCC3)s2)cnc1N";"IC50";"'='";"450.0";"nM";"6.35";"";"370565";"UO_0000065";"13.99";"0.27";"3.69";"5.30";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3972829";"";"None";"424.53";"0";"3.49";"BDBM209679";"COc1ccc(NC(=O)c2cc(-c3ccc(CN4CCOCC4)s3)cnc2N)cc1";"IC50";"'='";"910.0";"nM";"6.04";"";"370569";"UO_0000065";"14.23";"0.28";"2.55";"6.73";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3945410";"";"None";"279.30";"0";"2.31";"BDBM209697";"Nc1ncc(-c2ccc[nH]2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"410.0";"nM";"6.39";"";"370584";"UO_0000065";"22.87";"0.42";"4.08";"6.61";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3650734";"";"None";"388.44";"0";"1.95";"BDBM148118";"Cn1nccc1Nc1nccc(-c2ccc(N3CCC[C@@H]3C(N)=O)c(C#N)c2)n1";"IC50";"'<'";"3000.0";"nM";"";"";"286099";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650742";"";"None";"456.51";"0";"2.83";"BDBM148126";"CNC(=O)[C@H]1CCCN1c1ccc(-c2ccnc(Nc3ccc(NC(C)=O)nc3)n2)cc1C#N";"IC50";"'<'";"9000.0";"nM";"";"";"286107";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4227907";"";"None";"1093.20";"None";"None";"3i";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCOCCCCOCCCOc2ccc(Nc3ncc(Br)c(NCCCN(C)C(=O)C4CCC4)n3)cc2)C(C)(C)C)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"8.13";"None";"None";"None";"0";"CHEMBL4219640";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219031";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3650744";"";"None";"446.53";"0";"3.68";"BDBM148128";"CN(C)CCNc1ccc(Nc2nccc(-c3ccc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286109";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4287123";"";"None";"322.32";"0";"2.63";"118";"CC(C)C#Cc1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"15.27";"0.28";"2.29";"4.62";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4280074";"";"None";"324.34";"0";"3.28";"124";"Nc1nc2oc3ccc(C4CCCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"17.71";"0.33";"2.46";"5.40";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4287304";"";"None";"338.36";"0";"3.67";"125";"Nc1nc2oc3ccc(C4CCCCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"16.91";"0.31";"2.05";"5.38";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4278727";"";"None";"394.38";"0";"2.93";"142";"Nc1nc2oc3ccc(C4=CCC5(CC4)OCCO5)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"15.53";"0.29";"3.19";"4.90";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4281733";"";"None";"367.36";"0";"1.96";"145";"Nc1nc2oc3ccc(C4CCN(C=O)CC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"17.18";"0.32";"4.35";"4.98";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3892127";"";"None";"409.52";"0";"3.18";"BDBM209661";"Cc1cnccc1NC(=O)c1cc(-c2ccc(CN3CCOCC3)s2)cnc1N";"IC50";"'='";"260.0";"nM";"6.58";"";"370551";"UO_0000065";"16.08";"0.31";"3.41";"7.05";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976366";"";"None";"337.34";"0";"0.66";"BDBM209665";"NC(=O)Cn1cc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)cn1";"IC50";"'='";"360.0";"nM";"6.44";"";"370555";"UO_0000065";"19.10";"0.35";"5.78";"4.54";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967420";"";"None";"348.36";"0";"2.76";"BDBM209670";"COC(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)cc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"370560";"UO_0000065";"16.64";"0.30";"3.04";"5.41";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975928";"";"None";"362.39";"0";"3.00";"BDBM209672";"Nc1ncc(-c2ccc(CCC(=O)O)cc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"250.0";"nM";"6.60";"";"370562";"UO_0000065";"18.22";"0.33";"3.60";"5.59";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3650732";"";"None";"442.48";"0";"2.57";"BDBM148116";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CCC[C@@H]4C(N)=O)c(C#N)c3)n2)cn1";"IC50";"'<'";"300.0";"nM";"";"";"286097";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4465099";"";"None";"413.48";"0";"3.09";"CYT387";"C#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4373768";"Competitive inhibition of TBK1 (unknown origin) upto 1 uM in presence of ATP by single point screening assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL2011933";"";"None";"458.36";"0";"4.11";"4h";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.32";"0.40";"4.29";"9.14";"1";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011945";"";"None";"476.35";"0";"4.25";"5d";"COc1ccc(F)cc1-c1nc2c(NCCCNC(=O)C3CCC3)c(Br)cnc2[nH]1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"15.53";"0.34";"3.15";"8.05";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4573638";"";"None";"472.55";"0";"3.50";"13";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)C6CCC6)CC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"2660.0";"nM";"5.58";"";"";"UO_0000065";"11.80";"0.22";"2.08";"4.80";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4566796";"";"None";"554.58";"1";"4.46";"30";"COCc1cc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"14.70";"0.28";"3.69";"7.27";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3125737";"";"None";"380.43";"0";"4.10";"6";"CNc1c(-c2ccc(C(=O)O)s2)cnc2[nH]c(-c3ccc(OC)cc3)nc12";"IC50";"'='";"1040.0";"nM";"5.98";"";"";"UO_0000065";"15.73";"0.30";"1.88";"5.98";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125720";"";"None";"575.74";"2";"5.25";"26";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(=O)NCC(C)C)cs4)cnc3[nH]2)cc1";"IC50";"'='";"388.0";"nM";"6.41";"";"";"UO_0000065";"11.14";"0.21";"1.16";"4.79";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125721";"";"None";"519.63";"1";"3.96";"25";"COc1ccc(-c2nc3c(NCCCNC(=O)C4CCCC4)c(-c4nc(C(N)=O)cs4)cnc3[nH]2)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"15.48";"0.30";"4.09";"5.44";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125729";"";"None";"420.54";"1";"5.14";"17";"CCC(C)CNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1";"IC50";"'='";"219.0";"nM";"6.66";"";"";"UO_0000065";"15.84";"0.30";"1.52";"8.33";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125733";"";"None";"364.43";"0";"3.72";"13";"CNC(=O)c1cc(-c2cnc3[nH]c(-c4ccc(OC)cc4)nc3c2)cs1";"IC50";"'='";"203.0";"nM";"6.69";"";"";"UO_0000065";"18.36";"0.35";"2.97";"8.38";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL2011896";"";"None";"484.44";"1";"5.61";"1b";"Brc1cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1NC1CCCC1";"IC50";"'='";"1220.0";"nM";"5.91";"";"";"UO_0000065";"12.21";"0.26";"0.30";"8.95";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011905";"";"None";"361.24";"0";"4.22";"2c";"CNc1c(Br)cnc2[nH]c(-c3ccc(OC(C)C)cc3)nc12";"IC50";"'='";"1410.0";"nM";"5.85";"";"";"UO_0000065";"16.20";"0.36";"1.63";"9.31";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011906";"";"None";"319.16";"0";"3.13";"2d";"CNc1c(Br)cnc2[nH]c(-c3ccc(O)cc3)nc12";"IC50";"'='";"201.0";"nM";"6.70";"";"";"UO_0000065";"20.98";"0.48";"3.57";"9.07";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011907";"";"None";"347.17";"0";"3.13";"2e";"CNc1c(Br)cnc2[nH]c(-c3ccc(C(=O)O)cc3)nc12";"IC50";"'='";"257.0";"nM";"6.59";"";"";"UO_0000065";"18.98";"0.43";"3.46";"7.25";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011913";"";"None";"363.22";"0";"3.45";"2k";"CNc1c(Br)cnc2[nH]c(-c3ccc(OC)c(OC)c3)nc12";"IC50";"'='";"345.0";"nM";"6.46";"";"";"UO_0000065";"17.79";"0.40";"3.01";"8.97";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011917";"";"None";"432.32";"0";"3.14";"2o";"CNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc12";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"15.61";"0.34";"3.61";"8.96";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011922";"";"None";"307.16";"0";"2.16";"2t";"CNc1c(Br)cnc2[nH]c(-c3cnn(C)c3)nc12";"IC50";"'='";"1520.0";"nM";"5.82";"";"";"UO_0000065";"18.94";"0.44";"3.66";"8.15";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011932";"";"None";"473.38";"0";"3.05";"4g";"COc1ccc(-c2nc3c(NCCCNC(=O)C4(CN)CC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.74";"0.38";"5.35";"7.12";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3687174";"";"None";"376.42";"0";"3.05";"BDBM144208";"Cn1ccc(Nc2nccc(-c3ccc(OC4CCOCC4)c(C#N)c3)n2)n1";"IC50";"'='";"130.0";"nM";"6.89";"";"280360";"UO_0000065";"18.29";"0.34";"3.84";"7.04";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650698";"";"None";"399.46";"0";"3.71";"BDBM148081";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286069";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650725";"";"None";"467.58";"0";"3.75";"BDBM148109";"CN1CCN(C(=O)c2cccc(Nc3nccc(-c4ccc(N5CCCC5)c(C#N)c4)n3)c2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286090";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650705";"";"None";"345.41";"0";"3.09";"BDBM148089";"Cn1cnc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)c1";"IC50";"'<'";"300.0";"nM";"";"";"286076";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4292344";"";"None";"314.27";"0";"2.79";"110";"C=C(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cc1F";"IC50";"'='";"794.33";"nM";"6.10";"";"";"UO_0000065";"19.41";"0.36";"3.31";"5.73";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3687179";"";"None";"455.52";"0";"4.01";"BDBM144213";"N#Cc1cc(-c2ccnc(Nc3cnn(CCn4cccn4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"460.0";"nM";"6.34";"";"280365";"UO_0000065";"13.91";"0.25";"2.33";"6.16";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682425";"";"None";"390.40";"0";"2.40";"BDBM144132";"N#Cc1cc(-c2ccnc(Nc3ccc(=O)[nH]n3)n2)ccc1OC1CCOCC1";"IC50";"'='";"1600.0";"nM";"5.80";"";"280378";"UO_0000065";"14.85";"0.27";"3.40";"4.61";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687120";"";"None";"458.52";"0";"3.55";"BDBM144153";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)nn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"88.0";"nM";"7.06";"";"280399";"UO_0000065";"15.39";"0.28";"3.51";"6.69";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687137";"";"None";"414.51";"0";"4.95";"BDBM144171";"[C-]#[N+]c1cc(-c2ccnc(Nc3ccn(C4CCNCC4)n3)c2)ccc1OCC1CC1";"IC50";"'='";"50.0";"nM";"7.30";"";"280416";"UO_0000065";"17.61";"0.32";"2.35";"10.68";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL5093111";"";"None";"494.62";"0";"3.19";"11";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(CN4CCOCC4)c3)ncc2C2CC2)cc1";"IC50";"'='";"2050.0";"nM";"5.69";"";"";"UO_0000065";"11.50";"0.22";"2.50";"4.64";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5088682";"";"None";"507.62";"1";"3.98";"21";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)ncc2C2CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL4446892";"";"None";"520.34";"1";"3.31";"GSK8612";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"339.0";"nM";"6.47";"";"";"UO_0000065";"12.43";"0.29";"3.16";"5.06";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL4284757";"";"None";"362.39";"0";"3.15";"168";"Nc1nc2oc3ccc(C4CCCCC4)cc3c(=O)c2cc1-c1nn[nH]n1";"IC50";"'='";"1905.46";"nM";"5.72";"";"";"UO_0000065";"15.78";"0.29";"2.57";"4.63";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL5083125";"";"None";"533.45";"1";"3.07";"6";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(CN4CCOCC4)c3)ncc2Br)cc1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"13.46";"0.30";"4.11";"5.86";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL2207199";"";"None";"432.53";"0";"3.40";"17e";"O=C(NCCCNc1nc(Nc2ccc(-n3cncn3)cc2)ncc1C1CC1)C1CCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.70";"0.36";"5.12";"7.77";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2207194";"";"None";"446.56";"0";"3.46";"16c";"O=C(NCCCNc1nc(Nc2cccc(Cn3cncn3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.09";"0.35";"5.06";"7.77";"0";"CHEMBL2213811";"Inhibition of TBK1 by radiometry";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2203069";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4456062";"";"None";"515.54";"1";"3.44";"2";"O=C(NCC1CC1)c1ccc2nc(Nc3cc(CN4CCN(C(=O)CC(F)(F)F)CC4)ccn3)[nH]c2c1";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"13.64";"0.26";"3.59";"6.62";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4436188";"";"None";"566.63";"2";"5.52";"25";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cnn(CC5CCC5)c4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.51";"0.27";"2.70";"8.66";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4538591";"BAY-440";"None";"574.01";"1";"4.47";"36; BAY-440";"CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3650750";"";"None";"402.46";"0";"2.19";"BDBM148134";"Cn1cc(Nc2nccc(-c3ccc(N4CCC(C(N)=O)CC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"300.0";"nM";"";"";"286115";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650691";"";"None";"384.44";"0";"3.46";"BDBM148074";"N#Cc1cc(-c2ccnc(Nc3ccc(C(N)=O)cc3)n2)ccc1N1CCCC1";"IC50";"'<'";"30.0";"nM";"";"";"286065";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3964075";"";"None";"314.33";"0";"1.28";"BDBM205216";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1cn[nH]c1";"IC50";"'='";"2700.0";"nM";"5.57";"";"363283";"UO_0000065";"17.72";"0.35";"4.29";"4.40";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935343";"";"None";"314.33";"0";"2.15";"BDBM205234";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccco1";"IC50";"'='";"3700.0";"nM";"5.43";"";"363292";"UO_0000065";"17.28";"0.34";"3.28";"4.89";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4786783";"";"None";"292.30";"0";"1.11";"66";"C#Cc1nc(Nc2cccc(CC(N)=O)c2)nc2[nH]cnc12";"IC50";"'='";"740.0";"nM";"6.13";"";"";"UO_0000065";"20.97";"0.38";"5.02";"5.59";"0";"CHEMBL4700135";"Inhibition of human TBK1 by kinase-profiling analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699418";"1";"Scientific Literature";"RSC Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL3968667";"";"None";"444.50";"0";"1.96";"BDBM245974";"N#Cc1cc(-c2ccnc(Nc3ccnc(N4CCOCC4)c3)n2)cnc1N1CC[C@H](O)C1";"IC50";"'<'";"30.0";"nM";"";"";"429057";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3687152";"";"None";"438.49";"0";"4.71";"BDBM144186";"N#Cc1cc(-c2ccnc(Nc3ccc(-c4cn[nH]c4)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"120.0";"nM";"6.92";"";"280338";"UO_0000065";"15.78";"0.29";"2.21";"6.36";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687156";"";"None";"440.43";"1";"5.34";"BDBM144190";"N#Cc1cc(-c2ccnc(Nc3ccc(C(F)(F)F)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"310.0";"nM";"6.51";"";"280342";"UO_0000065";"14.78";"0.28";"1.17";"8.13";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687160";"";"None";"402.45";"0";"3.81";"BDBM144194";"N#Cc1cc(-c2ccnc(Nc3cc(CO)ccn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"280346";"UO_0000065";"20.12";"0.37";"4.29";"8.07";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687170";"";"None";"430.51";"0";"3.65";"BDBM144204";"N#Cc1cc(-c2ccnc(Nc3cnn(C4CCNC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"280.0";"nM";"6.55";"";"280356";"UO_0000065";"15.22";"0.28";"2.90";"6.75";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687175";"";"None";"362.39";"0";"3.04";"BDBM144209";"N#Cc1cc(-c2ccnc(Nc3cn[nH]c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"280361";"UO_0000065";"22.69";"0.42";"5.18";"7.56";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687184";"";"None";"456.51";"0";"3.41";"BDBM144218";"N#Cc1cc(-c2ccnc(Nc3cnn(CCn4cccn4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"70.0";"nM";"7.16";"";"280370";"UO_0000065";"15.67";"0.29";"3.74";"6.18";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687186";"";"None";"473.58";"0";"3.90";"BDBM144220";"N#Cc1cc(-c2ccnc(Nc3cnn(CCC4CCNCC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"280372";"UO_0000065";"18.37";"0.34";"4.80";"7.91";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682421";"";"None";"416.44";"0";"4.01";"BDBM144128";"N#Cc1cc(-c2ccnc(Nc3cc(C(=O)O)ccn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"170.0";"nM";"6.77";"";"280374";"UO_0000065";"16.26";"0.30";"2.76";"5.77";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682422";"";"None";"456.55";"0";"4.18";"BDBM144129";"N#Cc1cc(-c2ccnc(Nc3ncc(C4CCNCC4)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"100.0";"nM";"7.00";"";"280375";"UO_0000065";"15.33";"0.28";"2.82";"6.67";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3980518";"";"None";"448.51";"0";"3.28";"BDBM245950";"CC(C)(O)CNc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429033";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3923611";"";"None";"521.53";"1";"2.51";"BDBM245991";"N#Cc1cc(-c2nc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)ncc2F)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429074";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915999";"";"None";"448.51";"0";"2.83";"BDBM246010";"COCCNCc1cncc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)c1";"IC50";"'<'";"100.0";"nM";"";"";"429093";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3956235";"";"None";"447.47";"0";"2.42";"BDBM246043";"N#Cc1cc(-c2ccnc(Nc3ccc(C(=O)NCCO)cc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429126";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892819";"";"None";"527.59";"2";"2.05";"BDBM246091";"N#Cc1nc(-c2ccnc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)n2)ccc1N1CCC2(COC2)C1";"IC50";"'<'";"100.0";"nM";"";"";"429174";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4245507";"";"None";"437.57";"0";"3.06";"28";"O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4233363";"Inhibition of NAK (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229420";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3968131";"";"None";"408.53";"0";"2.80";"BDBM205181";"CN1CCN(Cc2ccc(Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"1700.0";"nM";"5.77";"";"363257";"UO_0000065";"14.12";"0.27";"2.97";"6.60";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3936038";"";"None";"384.42";"0";"2.57";"BDBM205215";"COc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1OC";"IC50";"'='";"1500.0";"nM";"5.82";"";"363282";"UO_0000065";"15.15";"0.29";"3.25";"5.00";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955236";"";"None";"330.39";"0";"2.62";"BDBM205239";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccsc1";"IC50";"'='";"200.0";"nM";"6.70";"";"363297";"UO_0000065";"20.28";"0.42";"4.08";"6.84";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3687117";"";"None";"419.51";"0";"4.65";"BDBM144150";"N#Cc1cc(-c2ccnc(Nc3nc(C4CC4)cs3)n2)ccc1OC1CCOCC1";"IC50";"'='";"300.0";"nM";"6.52";"";"280396";"UO_0000065";"15.55";"0.30";"1.87";"7.02";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687139";"";"None";"345.41";"0";"4.27";"BDBM144173";"N#Cc1cc(-c2ccnc(Nc3cn[nH]c3)c2)ccc1OCC1CCC1";"IC50";"'='";"380.0";"nM";"6.42";"";"280418";"UO_0000065";"18.59";"0.34";"2.15";"7.41";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3896182";"";"None";"418.53";"0";"3.08";"BDBM205219";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C#N)cc2)CC1";"IC50";"'='";"8200.0";"nM";"5.09";"";"363286";"UO_0000065";"12.15";"0.23";"2.01";"5.97";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125741";"";"None";"351.39";"0";"4.06";"10";"COc1ccc(-c2nc3cc(-c4csc(C(=O)O)c4)cnc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125740";"";"None";"335.32";"0";"3.59";"9";"COc1ccc(-c2nc3cc(-c4cc(C(=O)O)co4)cnc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3125739";"";"None";"351.39";"0";"4.06";"8";"COc1ccc(-c2nc3cc(-c4cc(C(=O)O)cs4)cnc3[nH]2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3132510";"Inhibition of TBK1 in HEK293 cells after 4.5 hrs by ISRE-luciferase reporter gene assay in presence of poly I:C";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3307715";"";""
"CHEMBL3650741";"";"None";"401.43";"0";"2.29";"BDBM148125";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CC(O)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286106";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650697";"";"None";"396.45";"0";"3.85";"Domainex";"N#Cc1cc(-c2ccnc(Nc3ccc4c(c3)CC(=O)N4)n2)ccc1N1CCCC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.70";"0.41";"5.15";"9.58";"0";"CHEMBL4373769";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL3605057";"";"None";"464.61";"0";"3.65";"MRT67307";"O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"16.62";"0.31";"4.07";"8.45";"0";"CHEMBL4373769";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL3650697";"";"None";"396.45";"0";"3.85";"BDBM148080";"N#Cc1cc(-c2ccnc(Nc3ccc4c(c3)CC(=O)N4)n2)ccc1N1CCCC1";"IC50";"'<'";"30.0";"nM";"";"";"286068";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3931256";"";"None";"459.56";"0";"3.11";"BDBM246022";"COCCNc1ncc(-c2ccnc(Nc3ccc(NC4CCN(C)CC4)nc3)n2)cc1C#N";"IC50";"'<'";"1000.0";"nM";"";"";"429105";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927876";"";"None";"415.51";"0";"3.10";"BDBM246023";"CNc1ncc(-c2ccnc(Nc3ccc(NC4CCN(C)CC4)nc3)n2)cc1C#N";"IC50";"'<'";"100.0";"nM";"";"";"429106";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3985522";"";"None";"402.46";"0";"2.38";"BDBM246039";"Cn1cc(Nc2nccc(-c3cnc(N4C5CCC4CC(O)C5)c(C#N)c3)n2)cn1";"IC50";"'<'";"15.0";"nM";"";"";"429122";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916897";"";"None";"487.57";"0";"2.30";"BDBM246065";"CC(C)C(Nc1ncc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cc1C#N)C(N)=O";"IC50";"'<'";"15.0";"nM";"";"";"429148";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3923747";"";"None";"446.49";"0";"2.93";"BDBM245964";"N#Cc1cc(-c2ccnc(Nc3ccnc(N4CCOCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429047";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3984886";"";"None";"404.41";"0";"2.20";"BDBM246042";"N#Cc1cc(-c2ccnc(Nc3ccc(C(N)=O)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429125";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3957288";"";"None";"463.52";"0";"2.23";"BDBM246048";"N#Cc1cc(-c2ccnc(Nc3cnn(CCN4CCOCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429131";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894306";"";"None";"505.53";"1";"3.08";"BDBM246079";"N#Cc1nc(-c2ccnc(Nc3ccc(NC(=O)CN4CC[C@H](F)C4)nc3)n2)ccc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429162";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941194";"";"None";"462.51";"0";"3.64";"BDBM246084";"N#Cc1nc(-c2ccnc(Nc3ccc(CN4CC[C@H](F)C4)nc3)n2)ccc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429167";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3985241";"";"None";"484.56";"0";"2.61";"BDBM246089";"N#Cc1nc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)ccc1N1CCC2(COC2)C1";"IC50";"'<'";"30.0";"nM";"";"";"429172";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919706";"";"None";"394.50";"0";"3.42";"BDBM209652";"Nc1ncc(-c2ccc(CN3CCCCC3)s2)nc1C(=O)Nc1ccncc1";"IC50";"'='";"4000.0";"nM";"5.40";"";"370543";"UO_0000065";"13.68";"0.26";"1.98";"5.56";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3937942";"";"None";"338.37";"0";"1.82";"BDBM209643";"COCCn1cc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)cn1";"IC50";"'='";"7800.0";"nM";"5.11";"";"370643";"UO_0000065";"15.10";"0.28";"3.29";"4.73";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899705";"";"None";"439.54";"0";"3.27";"BDBM209646";"CCOc1cc(NC(=O)c2cc(-c3ccc(CN4CCOCC4)s3)cnc2N)ccn1";"IC50";"'='";"3000.0";"nM";"5.52";"";"370645";"UO_0000065";"12.57";"0.24";"2.25";"5.38";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980829";"";"None";"396.48";"0";"2.27";"BDBM209655";"Nc1ncc(-c2ccc(CN3CCOCC3)s2)cc1C(=O)Nc1ccnnc1";"IC50";"'='";"9300.0";"nM";"5.03";"";"370647";"UO_0000065";"12.69";"0.25";"2.76";"4.74";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4549667";"TP-030-2";"None";"481.35";"0";"3.12";"EUB0000720";"CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4885167";"TBK1(TBK1CGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507326";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM";""
"CHEMBL4634634";"";"None";"365.44";"0";"1.44";"29";"C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4603639";"Inhibition of recombinant full length human GST-tagged TBK1 expressed in insect expression system using serine/threonine-5 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";""
"CHEMBL3650751";"";"None";"429.48";"0";"3.34";"BDBM148135";"CO[C@H]1CCN(c2ccc(-c3ccnc(Nc4ccc(NC(C)=O)nc4)n3)cc2C#N)C1";"IC50";"'<'";"30.0";"nM";"";"";"286116";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650716";"";"None";"428.54";"0";"3.73";"BDBM148100";"CN(C)CCNc1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286083";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3923590";"";"None";"410.46";"0";"1.79";"BDBM205217";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(N2CCOCC2)nc1";"IC50";"'='";"7300.0";"nM";"5.14";"";"363284";"UO_0000065";"12.51";"0.24";"3.35";"4.16";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3956718";"";"None";"338.39";"0";"2.86";"BDBM205229";"Cc1ccc(C(=O)Nc2sc(-c3ccncc3)nc2C(N)=O)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"363287";"UO_0000065";"14.78";"0.28";"2.14";"5.10";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3956252";"";"None";"339.38";"0";"2.14";"BDBM205232";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccc(N)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"363290";"UO_0000065";"20.50";"0.40";"4.82";"5.61";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3936692";"";"None";"375.44";"0";"1.78";"BDBM209649";"Nc1ncc(-c2ccc(N3CCNCC3)nc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"770.0";"nM";"6.11";"";"370541";"UO_0000065";"16.28";"0.30";"4.33";"5.61";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975991";"";"None";"384.44";"0";"3.53";"BDBM209657";"Cc1cc(NC(=O)c2cc(-c3cnn(Cc4ccccc4)c3)cnc2N)ccn1";"IC50";"'='";"330.0";"nM";"6.48";"";"370547";"UO_0000065";"16.86";"0.31";"2.95";"6.57";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952415";"";"None";"352.40";"0";"2.13";"BDBM209662";"COCCn1cc(-c2cnc(N)c(C(=O)Nc3ccncc3C)c2)cn1";"IC50";"'='";"690.0";"nM";"6.16";"";"370552";"UO_0000065";"17.48";"0.32";"4.03";"5.71";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915602";"";"None";"339.36";"0";"1.22";"BDBM209664";"COCCn1cc(-c2cnc(N)c(C(=O)Nc3ccnnc3)c2)cn1";"IC50";"'='";"1200.0";"nM";"5.92";"";"370554";"UO_0000065";"17.45";"0.32";"4.70";"4.90";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3937785";"";"None";"334.34";"0";"2.68";"BDBM209671";"Nc1ncc(-c2ccc(C(=O)O)cc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"400.0";"nM";"6.40";"";"370561";"UO_0000065";"19.14";"0.35";"3.72";"5.41";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3931286";"";"None";"329.36";"0";"3.46";"BDBM209696";"Nc1ncc(-c2c[nH]c3ccccc23)cc1C(=O)Nc1ccncc1";"IC50";"'='";"510.0";"nM";"6.29";"";"370583";"UO_0000065";"19.11";"0.34";"2.83";"6.51";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892127";"";"None";"409.52";"0";"3.18";"BDBM209661";"Cc1cnccc1NC(=O)c1cc(-c2ccc(CN3CCOCC3)s2)cnc1N";"IC50";"'='";"7000.0";"nM";"5.16";"";"370649";"UO_0000065";"12.59";"0.24";"1.97";"5.52";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3682431";"";"None";"406.45";"0";"2.51";"BDBM144138";"N#Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"280384";"UO_0000065";"20.97";"0.39";"6.01";"7.22";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682435";"";"None";"405.46";"0";"3.11";"BDBM144142";"N#Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"120.0";"nM";"6.92";"";"280388";"UO_0000065";"17.07";"0.32";"3.81";"6.58";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687113";"";"None";"459.55";"0";"3.61";"BDBM144146";"N#Cc1cc(-c2ccnc(Nc3cnn(CCN4CCCC4)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"60.0";"nM";"7.22";"";"280392";"UO_0000065";"15.72";"0.29";"3.61";"7.14";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687115";"";"None";"458.52";"0";"3.55";"BDBM144148";"N#Cc1cc(-c2ccnc(Nc3cncc(N4CCOCC4)n3)c2)ccc1OC1CCOCC1";"IC50";"'='";"330.0";"nM";"6.48";"";"280394";"UO_0000065";"14.14";"0.26";"2.93";"6.15";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687118";"";"None";"483.57";"0";"4.15";"BDBM144151";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CC5(COC5)C4)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"41.0";"nM";"7.39";"";"280397";"UO_0000065";"15.28";"0.28";"3.24";"7.98";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687141";"";"None";"386.46";"0";"4.43";"BDBM144175";"N#Cc1cc(-c2ccnc(Nc3ccc(CO)cn3)c2)ccc1OCC1CCC1";"IC50";"'='";"89.0";"nM";"7.05";"";"280420";"UO_0000065";"18.24";"0.33";"2.62";"7.74";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3928378";"";"None";"491.55";"0";"3.90";"BDBM245943";"CN1CCC(Nc2ccc(Nc3nccc(-c4cnc(N5CCC(F)(F)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"429026";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3687153";"";"None";"417.51";"0";"4.94";"BDBM144187";"CC(C)(C)c1cc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ccn2)n[nH]1";"IC50";"'='";"21.0";"nM";"7.68";"";"280339";"UO_0000065";"18.39";"0.34";"2.74";"8.01";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687164";"";"None";"474.57";"0";"3.45";"BDBM144198";"N#Cc1cc(-c2ccnc(Nc3cnn(CCN4CCOCC4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"100.0";"nM";"7.00";"";"280350";"UO_0000065";"14.75";"0.27";"3.55";"7.18";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687185";"";"None";"426.43";"0";"3.78";"BDBM144219";"N#Cc1cc(-c2ccnc(Nc3cnn(CC(F)F)c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"5.0";"nM";"8.30";"";"280371";"UO_0000065";"19.47";"0.37";"4.52";"8.48";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682424";"";"None";"404.43";"0";"2.41";"BDBM144131";"Cn1nc(Nc2nccc(-c3ccc(OC4CCOCC4)c(C#N)c3)n2)ccc1=O";"IC50";"'='";"160.0";"nM";"6.80";"";"280377";"UO_0000065";"16.80";"0.31";"4.39";"5.91";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3682428";"";"None";"456.55";"0";"4.18";"BDBM144135";"N#Cc1cc(-c2ccnc(Nc3cnc(C4CCNCC4)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"10.0";"nM";"8.00";"";"280381";"UO_0000065";"17.52";"0.32";"3.82";"7.62";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687114";"";"None";"470.58";"0";"4.07";"BDBM144147";"CN1CCN(c2ccnc(Nc3cc(-c4ccc(OC5CCOCC5)c(C#N)c4)ccn3)c2)CC1";"IC50";"'='";"350.0";"nM";"6.46";"";"280393";"UO_0000065";"13.72";"0.25";"2.39";"7.46";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3943921";"";"None";"338.39";"0";"3.24";"BDBM209693";"CC(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)s1";"IC50";"'='";"160.0";"nM";"6.80";"";"370580";"UO_0000065";"20.08";"0.39";"3.56";"6.94";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955566";"";"None";"443.51";"0";"2.56";"BDBM246071";"N#Cc1nc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)ccc1N1CC[C@H](O)C1";"IC50";"'<'";"15.0";"nM";"";"";"429154";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904420";"";"None";"460.52";"0";"2.93";"BDBM246077";"N#Cc1nc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)ccc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429160";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947772";"";"None";"473.52";"0";"2.03";"BDBM246094";"N#Cc1nc(-c2ccnc(Nc3ccc(CN4CCNC(=O)C4)nc3)n2)ccc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429177";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927043";"";"None";"385.43";"0";"2.85";"BDBM245930";"N#Cc1cc(-c2ccnc(Nc3cccc(C(N)=O)c3)n2)cnc1N1CCCC1";"IC50";"'<'";"30.0";"nM";"";"";"429013";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3922677";"";"None";"486.56";"0";"3.18";"BDBM245939";"N#Cc1cc(-c2ccnc(Nc3cccc(C(=O)NC4CCNCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429022";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940936";"";"None";"471.57";"0";"2.63";"BDBM245941";"CN1CCC(Nc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](O)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"429024";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3985538";"";"None";"459.53";"0";"2.85";"BDBM245952";"CN1CCN(c2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"15.0";"nM";"";"";"429035";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943824";"";"None";"502.56";"1";"1.94";"BDBM245959";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CN4CCNCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429042";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3901208";"";"None";"350.36";"0";"2.43";"BDBM245967";"N#Cc1cc(-c2ccnc(Nc3ccn[nH]3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"1000.0";"nM";"";"";"429050";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3912853";"";"None";"472.55";"0";"2.61";"BDBM245987";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CCCOCC1";"IC50";"'<'";"100.0";"nM";"";"";"429070";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3960782";"";"None";"448.51";"0";"2.52";"BDBM246007";"CN(CCO)Cc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429090";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125739";"";"None";"351.39";"0";"4.06";"8";"COc1ccc(-c2nc3cc(-c4cc(C(=O)O)cs4)cnc3[nH]2)cc1";"IC50";"'='";"129.0";"nM";"6.89";"";"";"UO_0000065";"19.61";"0.38";"2.83";"7.82";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL572878";"TOZASERTIB";"2.0";"464.60";"0";"3.50";"Tozasertib";"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1";"IC50";"'='";"6.22";"nM";"8.21";"";"";"UO_0000065";"17.66";"0.34";"4.71";"8.04";"0";"CHEMBL4373750";"Inhibition of TBK1 (unknown origin) using biotinylated peptide as substrate preincubated for 30 mins by fluorescence activity-based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL3974895";"";"None";"367.37";"0";"0.94";"BDBM209651";"Nc1ncc(-c2cnn(CC3OCCO3)c2)nc1C(=O)Nc1ccncc1";"IC50";"'='";"8300.0";"nM";"5.08";"";"370542";"UO_0000065";"13.83";"0.26";"4.14";"3.91";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4453481";"";"None";"512.54";"1";"4.18";"22";"CCn1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)cn1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"12.24";"0.23";"2.10";"6.61";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4538751";"";"None";"524.55";"1";"4.62";"29";"Cc1cc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.81";"0.28";"3.15";"7.55";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4459120";"";"None";"443.43";"0";"3.17";"1";"N#Cc1ccc2nc(Nc3cc(CN4CCN(C(=O)CC(F)(F)F)CC4)ccn3)[nH]c2c1";"IC50";"'='";"618.0";"nM";"6.21";"";"";"UO_0000065";"14.00";"0.26";"3.04";"6.15";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"3.86";"nM";"8.41";"";"";"UO_0000065";"18.03";"0.33";"4.06";"12.11";"0";"CHEMBL4720531";"Inhibition of human TBK1 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"INHIBITOR"
"CHEMBL3924260";"";"None";"379.49";"0";"3.64";"BDBM209639";"Nc1ncc(-c2ccc(CN3CCCC3)s2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"130.0";"nM";"6.89";"";"370532";"UO_0000065";"18.15";"0.35";"3.25";"8.18";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4062803";"";"None";"320.36";"0";"3.73";"19";"Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4007750";"Inhibition of TBK1 (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3906387";"";"None";"356.39";"0";"3.16";"BDBM209642";"Nc1ncc(-c2ccc(-n3cccn3)cc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"120.0";"nM";"6.92";"";"370535";"UO_0000065";"19.42";"0.35";"3.76";"7.01";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3914197";"";"None";"409.52";"0";"3.18";"BDBM209654";"Cc1cc(NC(=O)c2cc(-c3csc(CN4CCOCC4)c3)cnc2N)ccn1";"IC50";"'='";"670.0";"nM";"6.17";"";"370545";"UO_0000065";"15.08";"0.29";"2.99";"6.61";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3901173";"";"None";"378.39";"0";"2.57";"BDBM209668";"COCCn1cc(-c2cnc(N)c(C(=O)Nc3ccnc4ccoc34)c2)cn1";"IC50";"'='";"1200.0";"nM";"5.92";"";"370558";"UO_0000065";"15.65";"0.29";"3.35";"4.89";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3970040";"";"None";"321.34";"0";"2.51";"BDBM209684";"CC(=O)c1c[nH]c(-c2cnc(N)c(C(=O)Nc3ccncc3)c2)c1";"IC50";"'='";"240.0";"nM";"6.62";"";"370572";"UO_0000065";"20.60";"0.38";"4.11";"5.82";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3687165";"";"None";"433.51";"0";"4.15";"BDBM144199";"COCCCn1cc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ccn2)cn1";"IC50";"'='";"120.0";"nM";"6.92";"";"280351";"UO_0000065";"15.96";"0.30";"2.77";"7.35";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687173";"";"None";"418.50";"1";"5.21";"BDBM144207";"CC(C)(C)c1cc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ccn2)on1";"IC50";"'='";"860.0";"nM";"6.07";"";"280359";"UO_0000065";"14.49";"0.27";"0.86";"6.51";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687183";"";"None";"455.47";"0";"4.16";"BDBM144217";"N#Cc1cc(-c2ccnc(Nc3ccc4oc(C(N)=O)cc4c3)n2)ccc1OC1CCOCC1";"IC50";"'='";"10.0";"nM";"8.00";"";"280369";"UO_0000065";"17.56";"0.32";"3.84";"5.87";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687119";"";"None";"456.55";"0";"4.18";"BDBM144152";"N#Cc1cc(-c2ccnc(Nc3nccc(C4CCNCC4)n3)c2)ccc1OC1CCOCC1";"IC50";"'='";"140.0";"nM";"6.85";"";"280398";"UO_0000065";"15.01";"0.28";"2.67";"6.53";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687144";"";"None";"474.57";"0";"4.52";"BDBM144178";"[C-]#[N+]c1cc(-c2ccnc(Nc3cnn(CCOC)c3)c2)ccc1OCC1CCN(C(C)=O)CC1";"IC50";"'='";"5500.0";"nM";"5.26";"";"280423";"UO_0000065";"11.08";"0.21";"0.74";"6.13";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650730";"";"None";"415.46";"0";"2.68";"BDBM148114";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CC[C@H](O)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286095";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4547610";"";"None";"542.57";"1";"4.55";"20";"CC(C)Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3907890";"";"None";"418.44";"0";"3.06";"BDBM245936";"CC(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429019";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935860";"";"None";"473.56";"0";"3.60";"BDBM245937";"CN1CCC(Nc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"429020";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3938197";"";"None";"517.57";"1";"2.76";"BDBM245960";"CC(C(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1)N1CCOCC1";"IC50";"'<'";"30.0";"nM";"";"";"429043";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932700";"";"None";"350.36";"0";"2.43";"BDBM245966";"N#Cc1cc(-c2ccnc(Nc3cn[nH]c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429049";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961080";"";"None";"377.38";"0";"2.39";"BDBM245976";"N#Cc1cc(-c2ccnc(Nc3cccc(=O)[nH]3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"1000.0";"nM";"";"";"429059";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935316";"";"None";"448.51";"0";"2.83";"BDBM245980";"COCCNCc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429063";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904385";"";"None";"473.52";"0";"2.03";"BDBM246005";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCNC(=O)C4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429088";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4446892";"";"None";"520.34";"1";"3.31";"GSK8612";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"158.49";"nM";"6.80";"";"";"UO_0000065";"13.07";"0.30";"3.49";"5.32";"0";"CHEMBL4364412";"Inhibition of recombinant human TBK1 using MBP as substrate in presence of gamma-33P]-ATP by Hotspot assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364239";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"";""
"CHEMBL4538174";"ERKi";"None";"311.35";"0";"2.33";"EUB0000298";"C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1";"IC50";"";"0.77";"µM";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4882610";"Invitrogen kinase screen (TBK1)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507286";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"";""
"CHEMBL2006765";"";"None";"392.39";"0";"3.82";"5";"CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"15.22";"0.29";"2.15";"6.30";"0";"CHEMBL4007750";"Inhibition of TBK1 (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4066664";"";"None";"348.29";"0";"3.82";"8";"FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4007750";"Inhibition of TBK1 (unknown origin) after 60 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007384";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4106630";"";"None";"406.45";"0";"1.30";"BDBM246034";"N#Cc1cc(-c2ccnc(Nc3cnn(C[C@@H](O)CO)c3)n2)cnc1N1CCCC1";"IC50";"'<'";"15.0";"nM";"";"";"429117";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115221";"";"None";"389.42";"0";"1.34";"BDBM246038";"Cn1cc(Nc2nccc(-c3cnc(N4CCC[C@@H]4C(N)=O)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429121";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3982149";"";"None";"376.40";"0";"2.68";"BDBM246053";"N#Cc1cc(-c2ccnc(Nc3ccc(N)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429136";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4575832";"";"None";"390.45";"0";"2.47";"5";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCNCC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"14700.0";"nM";"4.83";"";"";"UO_0000065";"12.38";"0.23";"2.36";"4.48";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4287847";"";"None";"299.29";"0";"2.14";"111";"CC(C)c1cc2c(=O)c3cc(C(=O)O)c(N)nc3oc2cn1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"20.86";"0.39";"4.10";"5.23";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL4290720";"";"None";"310.31";"0";"2.89";"123";"Nc1nc2oc3ccc(C4CCC4)cc3c(=O)c2cc1C(=O)O";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"17.20";"0.32";"2.45";"5.02";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL3925224";"";"None";"327.37";"0";"1.89";"BDBM205233";"Cn1cccc1C(=O)Nc1sc(-c2ccncc2)nc1C(N)=O";"IC50";"'='";"400.0";"nM";"6.40";"";"363291";"UO_0000065";"19.54";"0.38";"4.51";"6.22";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3687122";"";"None";"455.52";"0";"4.86";"BDBM144155";"N#Cc1cc(-c2ccnc(Nc3cncc(C4=CCCCO4)n3)c2)ccc1OC1CCOCC1";"IC50";"'='";"850.0";"nM";"6.07";"";"280401";"UO_0000065";"13.33";"0.24";"1.21";"5.94";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687126";"";"None";"456.55";"0";"4.18";"BDBM144159";"N#Cc1cc(-c2ccnc(Nc3cncc(C4CCNCC4)n3)c2)ccc1OC1CCOCC1";"IC50";"'='";"24.0";"nM";"7.62";"";"280405";"UO_0000065";"16.69";"0.31";"3.44";"7.26";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687127";"";"None";"444.54";"0";"4.61";"BDBM144160";"N#Cc1cc(-c2ccnc(Nc3cnn([C@H]4CC[C@@H](O)CC4)c3)n2)ccc1OCC1CCC1";"IC50";"'='";"11.0";"nM";"7.96";"";"280406";"UO_0000065";"17.90";"0.33";"3.35";"7.31";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687142";"";"None";"428.54";"1";"5.34";"BDBM144176";"[C-]#[N+]c1cc(-c2ccnc(Nc3ccn(C4CCNCC4)n3)c2)ccc1OCC1CCC1";"IC50";"'='";"65.0";"nM";"7.19";"";"280421";"UO_0000065";"16.77";"0.31";"1.85";"10.51";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1761510";"";"None";"319.41";"0";"3.40";"12";"NC(=O)c1cc(-c2ccccc2)cc2c(C3CCCNC3)c[nH]c12";"IC50";"'>'";"3162.28";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1764210";"Inhibition of TBK-1";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759890";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3884319";"";"None";"386.45";"0";"4.24";"33";"CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"12.94";"0.24";"0.76";"6.38";"0";"CHEMBL3876132";"Inhibition of human recombinant full length GST-tagged TBK1 expressed in insect expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875183";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL3936692";"";"None";"375.44";"0";"1.78";"BDBM209649";"Nc1ncc(-c2ccc(N3CCNCC3)nc2)cc1C(=O)Nc1ccncc1";"IC50";"'='";"9800.0";"nM";"5.01";"";"370646";"UO_0000065";"13.34";"0.24";"3.23";"4.59";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2011934";"";"None";"472.39";"0";"4.46";"4i";"COc1ccc(-c2nc3c(NCCCN(C)C(=O)C4CCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"17.57";"0.38";"3.84";"9.98";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011897";"";"None";"501.47";"1";"4.62";"1c";"CN(C)CCCNc1c(Br)cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc12";"IC50";"'='";"2290.0";"nM";"5.64";"";"";"UO_0000065";"11.25";"0.24";"1.02";"8.14";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011899";"";"None";"513.48";"1";"4.66";"1e";"Brc1cnc2[nH]c(-c3ccc(OCCN4CCCCC4)cc3)nc2c1NCC1CCNCC1";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"13.59";"0.29";"2.32";"8.94";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2011920";"";"None";"390.29";"0";"2.89";"2r";"CNc1c(Br)cnc2[nH]c(-c3cnn(C4CCN(C)CC4)c3)nc12";"IC50";"'='";"192.0";"nM";"6.72";"";"";"UO_0000065";"17.21";"0.38";"3.83";"9.00";"0";"CHEMBL2013355";"Inhibition of recombinant TBK1 using 5FAM-AhxKRRAL(ps)VASLPGL as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2010664";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3650719";"";"None";"429.53";"0";"3.69";"BDBM148103";"CN(C)CCOc1ccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"286086";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3360318";"";"None";"308.34";"0";"2.75";"3";"COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1";"IC50";"'>'";"4000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3388159";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351789";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL4279379";"";"None";"299.29";"0";"1.69";"113";"CN(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"21.38";"0.40";"4.71";"5.83";"0";"CHEMBL4276010";"Inhibition of human TBK1 (1 to 657 residues) expressed in Baculovirus infected SF9 insect cells using myelin basic protein as substrate in presence of [gamma-33P]-ATP by radiometric kinase assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4270652";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";""
"CHEMBL5091688";"";"None";"419.53";"0";"3.31";"14";"c1cc(CN2CCOCC2)cc(Nc2ncc(C3CC3)c(NCCc3c[nH]cn3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5084750";"";"None";"481.50";"0";"3.42";"5";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(C2CC2)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"149.0";"nM";"6.83";"";"";"UO_0000065";"14.18";"0.28";"3.41";"5.34";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL3687187";"";"None";"449.51";"1";"5.38";"BDBM47117";"N#Cc1cc(-c2ccnc(Nc3cncc(-c4cccnc4)c3)c2)ccc1OC1CCOCC1";"IC50";"'='";"260.0";"nM";"6.58";"";"198638";"UO_0000065";"14.65";"0.26";"1.21";"7.08";"0";"CHEMBL3706335";"Flashplate Assay: 1 nM IKKe, 800 nM biotinylated IkBalpha(19-42) peptide (Biotin-C6-C6-GLKKERLLDDRHDSGLDSMKDEE) and 10 Î¼M ATP (spiked with 0.3 uCi of 33P-ATP/well) are incubated at 30 C. for 2 hours in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM dithiothreitol, 0.02% of Brij35, 0.1% of BSA, 0.1% of BioStab, pH 7.5) with or without test compound. The reaction is stopped using 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 Î¼l of 0.9% sodium chloride solution. Non-specific reaction is determined in the presence of 3 uM MSC2119074 (BX-795). The radioactivity is measured using a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"34; BAY-985";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"13.59";"0.26";"3.14";"7.09";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3650746";"";"None";"443.51";"0";"3.73";"BDBM148130";"COC[C@H]1CCCN1c1ccc(-c2ccnc(Nc3ccc(NC(C)=O)nc3)n2)cc1C#N";"IC50";"'<'";"30.0";"nM";"";"";"286111";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3975991";"";"None";"384.44";"0";"3.53";"BDBM209657";"Cc1cc(NC(=O)c2cc(-c3cnn(Cc4ccccc4)c3)cnc2N)ccn1";"IC50";"'='";"8100.0";"nM";"5.09";"";"370648";"UO_0000065";"13.24";"0.24";"1.56";"5.16";"0";"CHEMBL3888072";"TBK1 Cell Assay: Assay Overview: MDA-MB-468 cells are detached with HyQ-Tase, counted, and seeded into a 384-well clear bottom TC-surface plate at density of 10,000 cells per well in a total volume of 35 ul complete medium. Alternatively cells are directly seeded from frozen vials. Cells are pre-treated with inhibitor compounds for 1 h prior to Poly(I:C) stimulation. After 2 h of incubation with Poly(I:C), cells are fixed in (para)formaldehyde (PFA) and permeabilized with methanol (MeOH). The cells are then blocked and incubated with an anti-pIRF3 antibody at 4oC overnight. The primary antibody is washed off, an AlexaFluor488-conjugated secondary is added, cells are counterstained with propidium iodide followed by image acquisition on IMX Ultra high content reader.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3650708";"";"None";"345.41";"0";"3.09";"BDBM148092";"Cn1cncc1Nc1nccc(-c2ccc(N3CCCC3)c(C#N)c2)n1";"IC50";"'<'";"300.0";"nM";"";"";"286079";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3901749";"";"None";"372.82";"0";"2.47";"BDBM209678";"COCCn1cc(-c2cnc(N)c(C(=O)Nc3ccncc3Cl)c2)cn1";"IC50";"'='";"740.0";"nM";"6.13";"";"370568";"UO_0000065";"16.44";"0.32";"3.66";"5.68";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950028";"";"None";"429.93";"0";"3.53";"BDBM209673";"Nc1ncc(-c2ccc(CN3CCOCC3)s2)cc1C(=O)Nc1ccncc1Cl";"IC50";"'='";"250.0";"nM";"6.60";"";"370563";"UO_0000065";"15.36";"0.31";"3.07";"7.07";"0";"CHEMBL3888070";"TBK1 : The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 uM ATP (spiked with 0.25 uCi 33P-ATP/well) are incubated in a total volume of 50 ul (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 ul 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ul 0.9% sodium chloride solution.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886561";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5088930";"";"None";"458.36";"0";"3.19";"9";"Brc1cnc(Nc2cccc(CN3CCOCC3)c2)nc1NCCc1c[nH]cn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5086901";"";"None";"406.42";"0";"3.54";"3";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(C2CC2)c(NCCc2c[nH]cn2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5083125";"";"None";"533.45";"1";"3.07";"6";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(CN4CCOCC4)c3)ncc2Br)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5087433";"";"None";"411.43";"0";"3.01";"8";"Cc1nn(CC(F)(F)F)cc1Nc1nccc(NCCCNC(=O)C2CCC2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5091582";"";"None";"366.35";"0";"2.67";"15";"Cc1nn(CC(F)(F)F)cc1Nc1nccc(NCCc2cnc[nH]2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5087006";"";"None";"467.56";"0";"3.11";"16";"NS(=O)(=O)c1ccc(CNc2ccnc(Nc3cccc(NC(=O)N4CCCC4)c3)n2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"";"2.0";"nM";"";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4884194";"Biochemical assay (low ATP) with TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"";""
"CHEMBL5079601";"";"None";"451.50";"0";"3.88";"4";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(C2CC2)c(NCCCNC(=O)C2CCC2)n1";"IC50";"'='";"192.0";"nM";"6.72";"";"";"UO_0000065";"14.88";"0.29";"2.84";"6.94";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL5088682";"";"None";"507.62";"1";"3.98";"21";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)ncc2C2CC2)cc1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"13.58";"0.26";"2.91";"4.84";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL4446892";"";"None";"520.34";"1";"3.31";"GSK8612";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"14.28";"0.33";"4.12";"5.81";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL3650745";"";"None";"442.48";"0";"2.57";"BDBM148129";"CC(=O)Nc1ccc(Nc2nccc(-c3ccc(N4CCC[C@H]4C(N)=O)c(C#N)c3)n2)cn1";"IC50";"'<'";"300.0";"nM";"";"";"286110";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"";"312.0";"nM";"";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4884197";"NanoBRET with TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Num of experiments None 2.0 None";""
"CHEMBL5079149";"";"None";"546.45";"1";"3.87";"13";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)ncc2Br)cc1";"IC50";"'='";"6170.0";"nM";"5.21";"";"";"UO_0000065";"9.53";"0.21";"1.34";"3.66";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5085430";"";"None";"516.44";"1";"4.33";"18";"O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br)C1CCC1";"IC50";"'='";"338.0";"nM";"6.47";"";"";"UO_0000065";"12.53";"0.27";"2.14";"5.82";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3650733";"";"None";"361.41";"0";"2.06";"BDBM148117";"Cn1nccc1Nc1nccc(-c2ccc(N3CC[C@H](O)C3)c(C#N)c2)n1";"IC50";"'<'";"300.0";"nM";"";"";"286098";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650753";"";"None";"472.57";"0";"4.21";"BDBM148137";"CN1CCC(Nc2ccc(Nc3nccc(-c4ccc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)CC1";"IC50";"'<'";"30.0";"nM";"";"";"286118";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650740";"";"None";"458.57";"0";"3.09";"BDBM148124";"CN(C)CCNc1ccc(Nc2nccc(-c3ccc(N4CCC(O)CC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"300.0";"nM";"";"";"286105";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650727";"";"None";"455.57";"0";"3.65";"BDBM148111";"CN(C)CCNC(=O)c1cccc(Nc2nccc(-c3ccc(N4CCCC4)c(C#N)c3)n2)c1";"IC50";"'<'";"30.0";"nM";"";"";"286092";"UO_0000065";"";"";"";"";"0";"CHEMBL3707833";"Time-Resolved Fluorescence-based Lanthascreen Assay: Inhibitions studies were performed using a time-resolved fluorescence-based Lanthascreen assay. Phosphorylation of a fluorescein-labelled substrate peptide is measured using terbium-labeled phosphospecific antibodies. Terbium is excited at 340 nm and the FRET energy transfer to fluorescein is measured at 495 and 520 nm. The emission ratio between 520 and 495 is a measure of the level of phosphorylation of the substrate by the kinase.Kinase inhibition assays (10 Î¼L) were performed at 20Â° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 Î¼M) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBÎ± substrate (DRHDSGLDSMKDE), 20 Î¼M ATP, 2 nM or 8 nM IKKÎµ or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639223";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL5089987";"";"None";"454.56";"0";"2.31";"19";"NS(=O)(=O)c1ccc(CNc2ccnc(Nc3cccc(CN4CCOCC4)c3)n2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5085698";"";"None";"379.47";"0";"2.43";"20";"c1cc(CN2CCOCC2)cc(Nc2nccc(NCCc3cnc[nH]3)n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL5090046";"";"None";"477.61";"0";"4.44";"22";"O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1C1CC1)C1CCC1";"IC50";"'='";"2580.0";"nM";"5.59";"";"";"UO_0000065";"11.70";"0.22";"1.15";"5.02";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3944797";"";"None";"364.39";"0";"2.44";"BDBM245935";"Cn1cc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429018";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3913990";"";"None";"444.47";"0";"3.45";"BDBM245947";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)C4CC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429030";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904988";"";"None";"505.56";"1";"2.61";"BDBM245949";"COCCN(C)CC(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429032";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904619";"";"None";"473.52";"0";"2.79";"BDBM245968";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)C4CCCN4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429051";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3901065";"";"None";"434.48";"0";"3.16";"BDBM245975";"COCCNc1cc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)ccn1";"IC50";"'<'";"15.0";"nM";"";"";"429058";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3931338";"";"None";"474.54";"0";"3.49";"BDBM245999";"CC(c1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1)N1CCOCC1";"IC50";"'<'";"15.0";"nM";"";"";"429082";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891771";"";"None";"474.54";"0";"3.32";"BDBM246006";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCCOCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429089";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3928470";"";"None";"503.54";"1";"2.37";"BDBM246012";"N#Cc1cc(-c2ccnc(Nc3cncc(NC(=O)CN4CCOCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429095";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3938562";"";"None";"416.45";"0";"2.71";"BDBM246017";"CC(=O)Nc1ccc(Nc2nccc(-c3cnc(NC4CCOC4)c(C#N)c3)n2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"429100";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3971833";"";"None";"394.41";"0";"1.89";"BDBM246046";"N#Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"30.0";"nM";"";"";"429129";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3933243";"";"None";"491.53";"0";"2.27";"BDBM246049";"COCCNCC(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429132";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3985372";"";"None";"447.48";"0";"2.38";"BDBM246051";"CC(N)C(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429134";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3890843";"";"None";"427.51";"0";"3.59";"BDBM246072";"N#Cc1nc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)ccc1N1CCCC1";"IC50";"'<'";"15.0";"nM";"";"";"429155";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4543618";"";"None";"568.60";"2";"5.10";"35";"CC(C)Oc1cncnc1-c1ccc2nc(Nc3cc([C@@H](C)N4CCN(C(=O)CC(F)(F)F)CC4)ccn3)[nH]c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.30";"0.29";"3.60";"7.76";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3968170";"";"None";"314.33";"0";"2.15";"BDBM205238";"NC(=O)c1nc(-c2ccncc2)sc1NC(=O)c1ccoc1";"IC50";"'='";"4600.0";"nM";"5.34";"";"363296";"UO_0000065";"16.98";"0.33";"3.19";"4.80";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4451595";"";"None";"538.58";"1";"4.43";"27";"CN(C)c1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ccn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"14.18";"0.27";"3.21";"8.19";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4575832";"";"None";"390.45";"0";"2.47";"5";"Cc1noc(-c2ccc3nc(Nc4cc(CN5CCNCC5)ccn4)[nH]c3c2)n1";"IC50";"'='";"764.0";"nM";"6.12";"";"";"UO_0000065";"15.67";"0.29";"3.65";"5.67";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4454902";"";"None";"580.62";"2";"5.10";"31";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(OCC5CC5)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.30";"0.27";"3.20";"7.40";"0";"CHEMBL4380518";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 1 mM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4453292";"";"None";"539.57";"1";"3.82";"33";"CN(C)c1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.91";"0.28";"4.23";"7.58";"0";"CHEMBL4380517";"Inhibition of recombinant full length human N-terminal His-tagged TBK1 using biotin-labelled Ahx-GDEDFSSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376867";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL577784";"BX-795";"None";"591.48";"1";"4.75";"BX795";"O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.90";"0.33";"3.47";"7.39";"1";"CHEMBL4373767";"Competitive inhibition of TBK1 (unknown origin) by immunoprecipitation method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4373628";"1";"Scientific Literature";"Medchemcomm";"2019";"None";"";""
"CHEMBL3125725";"";"None";"473.37";"0";"4.47";"21";"COc1ccc(-c2nc3c(OCCCNC(=O)C4CCCC4)c(Br)cnc3[nH]2)cc1";"IC50";"'='";"759.0";"nM";"6.12";"";"";"UO_0000065";"12.93";"0.28";"1.65";"6.87";"0";"CHEMBL3132514";"Inhibition of recombinant full-length TBK1 (unknown origin) using CK1tide as substrate by microfluidic mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL5084750";"";"None";"481.50";"0";"3.42";"5";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(C2CC2)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"7456.0";"nM";"5.13";"";"";"UO_0000065";"10.65";"0.21";"1.71";"4.01";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5072178";"";"None";"441.44";"0";"2.55";"12";"Cc1nn(CC(F)(F)F)cc1Nc1nccc(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL4446892";"";"None";"520.34";"1";"3.31";"GSK8612";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.53";"0.26";"2.69";"4.69";"0";"CHEMBL4364414";"Inhibition of TBK1 in human Ramos cells assessed as decrease in poly(I:C)-stimulated IRF3 phosphorylation at Ser396 residue preincubated for 60 mins followed by poly(I:C) addition and measured after 120 mins by Western blot analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Ramos";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4364239";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3307664";"";""
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"";"18.0";"nM";"";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4884195";"Biochemical assay (high ATP) with TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507318";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"";""
"CHEMBL1230165";"SILMITASERTIB";"2.0";"349.78";"0";"4.88";"1; CX-4945";"O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"21.32";"0.41";"2.58";"9.93";"0";"CHEMBL4710178";"Inhibition of recombinant human TBK1 in presence of ATP at Km concentration by radiometric filter-binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706554";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL5079920";"";"None";"490.33";"0";"3.77";"7";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCCCNC(=O)C2CCC2)n1";"IC50";"'='";"321.0";"nM";"6.49";"";"";"UO_0000065";"13.24";"0.30";"2.72";"6.71";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5075360";"";"None";"437.55";"0";"3.57";"17";"O=C(NCCCNc1ccnc(Nc2cccc(NC(=O)N3CCCC3)c2)n1)C1CCC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL3916849";"";"None";"471.36";"0";"3.99";"BX-912";"O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1";"IC50";"'='";"2327.0";"nM";"5.63";"";"";"UO_0000065";"11.95";"0.26";"1.64";"5.08";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3900993";"";"None";"371.41";"0";"2.38";"BDBM246037";"Cn1cc(Nc2nccc(-c3cnc(N4CCC[C@H]4C#N)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429120";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5079601";"";"None";"451.50";"0";"3.88";"4";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(C2CC2)c(NCCCNC(=O)C2CCC2)n1";"IC50";"'='";"2680.0";"nM";"5.57";"";"";"UO_0000065";"12.34";"0.24";"1.69";"5.76";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5076165";"";"None";"445.25";"0";"3.43";"10";"Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCCc2cnc[nH]2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5046589";"Displacement of tracer K5 from NLuc fused TBK1 (unknown origin) expressed in HEK293 cells by NanoBRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";""
"CHEMBL4097778";"TP-030n";"None";"458.54";"0";"1.13";"TP-030n";"CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4885451";"TBK1(TBK1CGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM";""
"CHEMBL3909307";"";"None";"518.57";"1";"3.67";"BDBM245956";"CN1CCC(NC(=O)c2ccc(Nc3ncc(F)c(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cc2)CC1";"IC50";"'<'";"15.0";"nM";"";"";"429039";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3910276";"";"None";"434.48";"0";"3.25";"BDBM245961";"N#Cc1cc(-c2ccnc(Nc3cnn(C4CCOCC4)c3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429044";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950524";"";"None";"502.55";"1";"3.59";"BDBM245963";"N#Cc1cc(-c2ccnc(Nc3ccc(NC(=O)CC4CC[C@H](O)C4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"100.0";"nM";"";"";"429046";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943587";"";"None";"460.52";"0";"2.93";"BDBM245971";"N#Cc1cc(-c2ccnc(Nc3ccc(CN4CCOCC4)nc3)n2)cnc1N1CC[C@H](F)C1";"IC50";"'<'";"15.0";"nM";"";"";"429054";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3970737";"";"None";"418.46";"0";"1.71";"BDBM246041";"N#Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)cnc1N1C2CCC1COC2";"IC50";"'<'";"100.0";"nM";"";"";"429124";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3979910";"";"None";"443.51";"0";"2.56";"BDBM246044";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cnc1N1CC[C@H](O)C1";"IC50";"'<'";"15.0";"nM";"";"";"429127";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305b";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5209991";"Affinity Phenotypic Cellular interaction (pIRF3 cell-based mechanistic assay in MDA-MB231 cells) EUB0000305b TBK1";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Negative control: BAY-440 | Protein family: Protein Kinase | Recomended concentration = 1.0 µM";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5169023";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"";"None";"Affinity Phenotypic Cellular Source Knowledge: https://doi.org/10.1021/acs.jmedchem.9b01460";"INHIBITOR"
"CHEMBL4538591";"BAY-440";"None";"574.01";"1";"4.47";"EUB0000701a";"CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl";"IC50";"'>'";"27000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5210156";"Affinity On-target Cellular interaction (NanoBRET assay (HEK293T cells)) EUB0000701a TBK1";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Negative control for BAY-985 | Protein family: Protein Kinase | Recomended concentration = 1.0 µM";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5169023";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"";"None";"Affinity On-target Cellular Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-985";""
"CHEMBL577784";"BX-795";"None";"591.48";"1";"4.75";"73; BX795";"O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.90";"0.33";"3.47";"7.39";"0";"CHEMBL5131710";"Inhibition of TBK1 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131375";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3922448";"";"None";"470.99";"0";"2.96";"BDBM205194";"CN1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4Cl)nc3C(N)=O)cc2)CC1";"IC50";"'='";"640.0";"nM";"6.19";"";"363261";"UO_0000065";"13.15";"0.26";"3.23";"5.93";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3973084";"";"None";"464.55";"0";"2.22";"BDBM205201";"CC(=O)N1CCN(Cc2ccc(C(=O)Nc3sc(-c4ccncc4)nc3C(N)=O)cc2)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"363268";"UO_0000065";"14.75";"0.28";"4.63";"5.64";"0";"CHEMBL3887915";"TBK1 Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay assay (for e.g. Topcount measurement. 0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) SEQ ID NO: 2 and 10 μM ATP (spiked with 0.25 μCi 33P-ATP/well) are incubated in a total volume of 50 μl (10 mM MOPS, 10 mM Mg-acetat, 0.1 mM EGTA, 1 mM DTT, 0.02% Brij35, 0.1% BSA, pH 7.5) with or without test compound for 120 Min at 30° C. The reaction is stopped with 25 μl 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 μl 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886503";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5093111";"";"None";"494.62";"0";"3.19";"11";"NS(=O)(=O)c1ccc(CNc2nc(Nc3cccc(CN4CCOCC4)c3)ncc2C2CC2)cc1";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"13.60";"0.26";"3.54";"5.49";"0";"CHEMBL5046601";"Inhibition of human TTBK1 (1 to 479 residues) using Casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5046221";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL3687150";"";"None";"375.43";"0";"3.66";"BDBM144184";"Cn1ccc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ccn2)n1";"IC50";"'='";"97.0";"nM";"7.01";"";"280336";"UO_0000065";"18.68";"0.34";"3.35";"8.25";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687154";"";"None";"397.44";"0";"4.19";"BDBM144188";"N#Cc1ccc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ccn2)nc1";"IC50";"'='";"250.0";"nM";"6.60";"";"280340";"UO_0000065";"16.61";"0.30";"2.41";"6.36";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687178";"";"None";"415.45";"0";"3.42";"BDBM144212";"N#Cc1cc(-c2ccnc(Nc3ccc(C(N)=O)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"32.0";"nM";"7.50";"";"280364";"UO_0000065";"18.04";"0.33";"4.07";"6.09";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687128";"";"None";"457.53";"0";"4.61";"BDBM144161";"N#Cc1cc(-c2ccnc(Nc3cnc(C4CCOCC4)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"5.0";"nM";"8.30";"";"280407";"UO_0000065";"18.14";"0.33";"3.69";"8.12";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687129";"";"None";"403.44";"0";"3.20";"BDBM144162";"N#Cc1cc(-c2ccnc(Nc3cnc(CO)cn3)c2)ccc1OC1CCOCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"280408";"UO_0000065";"20.38";"0.37";"5.02";"7.26";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687135";"";"None";"389.46";"0";"4.00";"BDBM144169";"COCCn1cc(Nc2cc(-c3ccc(OCC4CC4)c(C#N)c3)ccn2)cn1";"IC50";"'='";"220.0";"nM";"6.66";"";"280414";"UO_0000065";"17.09";"0.31";"2.66";"7.83";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687138";"";"None";"427.51";"0";"4.38";"BDBM144172";"N#Cc1cc(-c2ccnc(Nc3ccc(N4CCOCC4)cn3)c2)ccc1OCC1CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"280417";"UO_0000065";"17.87";"0.33";"3.26";"9.17";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687145";"";"None";"457.53";"0";"4.57";"BDBM144179";"[C-]#[N+]c1cc(-c2ccnc(Nc3ccc(CO)cn3)c2)ccc1OCC1CCN(C(C)=O)CC1";"IC50";"'='";"1500.0";"nM";"5.82";"";"280424";"UO_0000065";"12.73";"0.23";"1.25";"6.33";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687146";"";"None";"499.62";"0";"4.80";"BDBM144180";"[C-]#[N+]c1cc(-c2ccnc(Nc3cnn(C4CCNCC4)c3)c2)ccc1OCC1CCN(C(C)=O)CC1";"IC50";"'='";"6600.0";"nM";"5.18";"";"280425";"UO_0000065";"10.37";"0.19";"0.38";"5.84";"0";"CHEMBL3706282";"Flashplate Assay: The kinase assay is performed as 384-well flashplate assay (for example for Topcount measurement).0.6 nM TANK binding kinase (TBK1), 800 nM biotinylated MELK-derived peptide (Biotin-Ah-Ah-AKPKGNKDYHLQTCCGSLAYRRR) and 10 uM ATP (spiked with 0.25 uCi of 33P-ATP/well) are incubated at 30 C. for 120 min in a total volume of 50 ul (10 mM MOPS, 10 mM Mg acetate, 0.1 mM EGTA, 1 mM DTT, 0.02% of Brij35, 0.1% of BSA, pH 7.5) with or without test compound. The reaction is stopped with 25 ul of 200 mM EDTA. After 30 min at room temperature, the liquid is removed, and each well is washed three times with 100 ul of 0.9% sodium chloride solution. Non-specific reaction is measured in the presence of 100 nM staurosporine. The radioactivity is measured in a Topcount (PerkinElmer).";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638777";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3962112";"";"None";"498.53";"0";"3.24";"BDBM246052";"Cc1nccn1CC(=O)Nc1ccc(Nc2nccc(-c3cnc(N4CC[C@H](F)C4)c(C#N)c3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429135";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932195";"";"None";"462.53";"0";"3.18";"BDBM246086";"COCCN(C)Cc1ccc(Nc2nccc(-c3ccc(N4CC[C@H](F)C4)c(C#N)n3)n2)cn1";"IC50";"'<'";"30.0";"nM";"";"";"429169";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3934438";"";"None";"376.42";"0";"1.94";"BDBM246031";"N#Cc1cc(-c2ccnc(Nc3cnn(CCO)c3)n2)cnc1N1CCCC1";"IC50";"'<'";"30.0";"nM";"";"";"429114";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3896086";"";"None";"388.44";"0";"2.25";"BDBM246040";"Cn1cc(Nc2nccc(-c3cnc(N4C5CCC4COC5)c(C#N)c3)n2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"429123";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3954923";"";"None";"501.55";"2";"1.39";"BDBM246075";"N#Cc1nc(-c2ccnc(Nc3ccc(NC(=O)CN4CCOCC4)nc3)n2)ccc1N1CC[C@H](O)C1";"IC50";"'<'";"100.0";"nM";"";"";"429158";"UO_0000065";"";"";"";"";"0";"CHEMBL3889017";"Time-Resolved Fluorescence-based Lanthascreen Assay: Kinase inhibition assays (10 μL) were performed at 20° C. in 384-well plate format. Compound IC50 values were determined at the apparent Km for ATP (20 μM) based on a radiometric assay (Invitrogen) using 8 or 10 point curves in duplicate. The final reaction conditions contained 400 nM fluorescein-IkBα substrate (DRHDSGLDSMKDE), 20 μM ATP, 2 nM or 8 nM IKKε or TBK1 kinase respectively, and 3% DMSO in kinase assay buffer consisting of 50 mM HEPES (pH 7.5), 10 mM MgCl, 1 mM EGTA, 0.01% Brij-35.Compound dilutions were prepared from 10 mM DMSO stocks by dilution into DMSO. Compound dilution series were further diluted in kinase assay buffer to give a 12% DMSO stock, the final concentration in the assay being 3% DMSO.The kinase phosphorylation assay was initiated by the addition of the kinase and the reaction was allowed to proceed for 1 h or 2.5 h for IKKε and TBK-1 kinase respectively.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886918";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL1230165";"SILMITASERTIB";"2.0";"349.78";"0";"4.88";"EUB0000613a";"O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"21.32";"0.41";"2.58";"9.93";"0";"CHEMBL5212838";"Selectivity interaction (Kinase panel (Millipore, radiometric filter-binding assay, conc. ATP = Km)) EUB0000613a TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Protein Kinase";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5169023";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"";"None";"Selectivity Comments: Ki = 0.38 nM (calculated via Cheng-Prussoff equation using IC50s by Millipore, PMID: 21174434); Cell viability assay in 13 cancer cell lines: IC50(MIA PaCA-2) = 1.1 µM, IC50(PC3) = 2.1 µM, IC50(HCT) = 2.2 µM, IC50(H1299) = 2.4 µM, IC50(Jurkat) = 2.5 µM, IC50(A549) = 3.0 µM, IC50(A375) = 3.9 µM, IC50(BxPC3) = 4.4 µM, IC50(LNCaP) = 4.7 µM, IC50(K-562) = 5.3 µM, IC50(MDA-MB-231) = 6.4 µM, IC50(MCF7) = 8.9 µM, IC50(Hs578T) = 13.1 µM (PMID: 21174434) | Selectivity number of off-targets = 7.0 None | Selectivity number of targets = 238.0 None | Selectivity Remarks: Screened at 0.5 µM (in-vitro potency) | Selectivity Source Knowledge: https://doi.org/10.1021/jm101251q";""
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305b";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.71";"0.30";"4.32";"8.19";"0";"CHEMBL5210410";"Affinity Biochemical interaction (TR-FRET-based kinase activity inhibition assay (1 µM ATP)) EUB0000305b TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Negative control: BAY-440 | Protein family: Protein Kinase | Recomended concentration = 1.0 µM";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5169023";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"";"None";"Affinity Biochemical Source Knowledge: https://doi.org/10.1021/acs.jmedchem.9b01460";"INHIBITOR"
"CHEMBL4538591";"BAY-440";"None";"574.01";"1";"4.47";"EUB0000701a";"CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl";"IC50";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"10.35";"0.20";"1.47";"5.60";"0";"CHEMBL5210415";"Affinity Biochemical interaction (TR-FRET-based kinase activity inhibition assay (1 µM ATP)) EUB0000701a TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Negative control for BAY-985 | Protein family: Protein Kinase | Recomended concentration = 1.0 µM";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5169023";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"";"None";"Affinity Biochemical Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/chemProbes#!specificprobeoverview/BAY-985";""
"CHEMBL5178711";"";"None";"507.96";"1";"4.27";"26; CS12192";"C=CC(=O)N(C)c1cc(Nc2ncc(Cl)c(NCCCNC(=O)c3ccc(C#N)cc3)n2)ccc1F";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"13.37";"0.26";"2.52";"5.52";"0";"CHEMBL5150290";"Inhibition of human TBK1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149965";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR"
"CHEMBL4537673";"BAY-985";"None";"553.59";"1";"4.38";"EUB0000305b";"C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1";"IC50";"'='";"312.0";"nM";"6.51";"";"";"UO_0000065";"11.75";"0.22";"2.13";"6.13";"0";"CHEMBL5210151";"Affinity On-target Cellular interaction (NanoBRET assay (HEK293T cells)) EUB0000305b TBK1";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Negative control: BAY-440 | Protein family: Protein Kinase | Recomended concentration = 1.0 µM";"";"";"CHEMBL5408";"Serine/threonine-protein kinase TBK1";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5169023";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"";"None";"Affinity On-target Cellular Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-985";"INHIBITOR"
